Novel fluoroelastomers composed of tetrafluoroethylene and vinylidene fluoride oligomers synthesized in carbon dioxide for use in soft lithography to enable a platform for the fabrication of shape- and size-specific, monodisperse biomaterials by Kelly, Jennifer Yvonne
NOVEL FLUOROELASTOMERS COMPOSED of TETRAFLUOROETHYLENE and 
VINYLIDENE FLUORIDE OLIGOMERS SYNTHESIZED in CARBON DIOXIDE for 
USE in SOFT LITHOGRAPHY to ENABLE a PLATFORM for the FABRICATION of 
SHAPE- and SIZE-SPECIFIC, MONODISPERSE BIOMATERIALS 
 
 
 
 
Jennifer Yvonne Kelly 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Chemistry 
 
Chapel Hill 
2008 
 
 
 
  
 
 
 
                                                                Approved By 
 
      Advisor: Joseph M. DeSimone 
 
            Reader: Maurice Brookhart 
 
            Reader: Ed Samulski  
 
       Reader: Jeffrey Johnson 
 
              Reader: Paul Resnick
 ii
©2008 
Jennifer Yvonne Kelly 
ALL RIGHTS RESERVED 
 
 
  iii
ABSTRACT 
JENNIFER YVONNE KELLY: Novel Fluoroelastomers Composed of Tetrafluoroethylene 
and Vinylidene Fluoride Oligomers Synthesized in Carbon Dioxide for Use in 
Soft Lithography to Enable a Platform for the Fabrication of Shape- and Size-
Specific, Monodisperse Biomaterials (Under the direction of Dr. Joseph M. 
DeSimone) 
 
 Fluorinated elastomers are materials with tremendous utility that have found use as 
minimally adhesive mold materials in soft lithography. The first objective of this research 
involved the synthesis of novel functional, fluorinated oligomers in supercritical carbon 
dioxide (scCO2) and the fabrication of the resulting fluorooligomers into solid elastomers 
using free radical crosslinking chemistry. Commercially available fluoroelastomers are 
typically synthesized in aqueous media using fluorinated surfactants or in non-aqueous 
conditions using fluorinated solvents. This research effort focused on the synthesis of low 
molecular weight oligomers consisting of tetrafluoroethylene (TFE) and vinylidene fluoride 
(VF2) with a cure site comonomer in scCO2 at low temperatures. Using CO2 as a 
polymerization medium allows for safe handling of TFE, is environmentally responsible by 
mitigating the typical generation of halogenated, organic, or aqueous waste, and circumvents 
the use of fluorinated surfactants as these copolymers are soluble in CO2. Investigations 
included characterizing the fluorinated oligomers and the solid elastomeric materials using 
NMR, DSC, TGA, GPC, IR, and via surface and mechanical property analysis.  
The second objective of this research included the use of fluoroelastomers as 
minimally adhesive mold materials in soft lithography applications using the Particle
  iii
Replication In Non-wetting Templates (PRINT™) technology for the fabrication of protein 
particles of discrete size and shape. Lyophilized protein particles are generally highly 
disperse in particle size, tend toward aggregation, and are often made through complicated 
processes. In attempts to engineer mono-disperse protein particles, the use of wet-milling, 
spray-freeze-drying, micro-emulsion, or super critical fluid methods have been reported. The 
PRINT process enables a gentle, facile route to mono-disperse particles composed of protein 
with and without cargo. This research objective included fabricating protein PRINT particles 
of varying sizes, shapes, and compositions (e.g., Abraxane, albumin, tranferrin, insulin, 
interferon-beta, hemoglobin, trypsin, horseradish peroxidase, and IgG). Several biophysical 
characterizations were performed to verify the protein structure was not significantly altered 
during the PRINT process, including SEM, FTIR, fluorescence microscopy, and CD. 
Furthermore, ELISA and enzymatic activity assays were performed to investigate biological 
integrity and function of all proteins.  The PRINT technology was found to be a gentle 
method to create nanoparticles of biologically relevant proteins.
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FLUOROELASTOMERS 
2 
1.0 Introduction. 
1.1 Fluoropolymers. Fluoropolymers are a special class of macromolecules, the most 
notable is poly(tetrafluoroethylene) (PTFE). Also known by DuPont’s trade name, 
Teflon® contains impeccable non-wetting and thermal stability characteristics most well-
known for its use in cook-ware applications.1-3 The commercial production of 
fluoropolymers is relatively small compared to their hydrocarbon analogues such as 
poly(ethylene) of poly(vinyl chloride).1 Fluoropolymer production with high resistance to 
deformation and high modulus includes fibers and polymers; plastics, flexible or rigid 
plastics having mechanical properties between fibers and elastomers; elastomers, having 
a completely amorphous morphology and some degree of crosslinking, can undergo very 
large, reversible elongations at relatively low stress; thermosets, chemically crosslinked 
polymers that do not flow when heated; thermoplastics, physically crosslinked polymers 
that do soften and flow when heated; and thermoplastic elastomers, elastomeric block 
copolymers containing a phase separated morphology and physical crosslinks.1, 3-5 The 
manufacturing of fluoropolymers for special applications is limited by their relatively 
high cost.1-3   
Fluorinated materials are relatively new and their development and use in a 
variety of applications remains largely unexplored. High performance polymers used in 
traditional industries, such as fabric coatings, fire retardant foams, wire coatings, o-rings, 
membranes, and coatings require exceptional properties.1, 3, 5 In many cases fluorinated 
materials outperform even the best hydrocarbon macromolecules. Fluorinated materials 
encompass unique applications and are particularly attractive compounds due to their 
versatility and broad range of properties. These properties include a wide range of 
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molecular weights, high thermal and mechanical stability, low temperature sustainability, 
chemical-, ageing-, and weather-resistance, solvent inertness, and oxidative stability, 
making them suitable for use in aggressive environments.1-3, 5 Furthermore, these 
compounds possess semi-crystalline or completely amorphous morphologies.5 The 
unique combination of these attributes with low indices of refraction, extremely low 
surface energies, nonflammable nature, and low dielectric constants is a result of the low 
polarizability and the strong electronegativity of the fluorine atom, its small Van der 
Waals radius and the strong C–F bond.6 
The fluorine content within a material greatly influences its properties. Polymers 
containing no aliphatic hydrogen bonds and only strong C–F and C–C bonds are termed 
“perfluorinated” and typically demonstrate the most resilient properties of fluorinated 
materials.3, 5, 7 For example, PTFE not only offers non-wetting properties, but also 
unsurpassed high temperature tolerances as a result of its high degree of crystallinity, 
high melting temperature, and high melt viscosity; compared to its aliphatic counterpart, 
poly(ethylene), which exhibits far less temperature stability.2, 3 The remarkable properties 
of high molecular weight PTFE were immediately evident with its accidental discovery, 
as were the difficulties of converting the materials into shape-specific objects since 
traditional solution and melt processing techniques were impossible to implement.2, 3, 8 
The need for a more easily processed form of PTFE led to discoveries of perfluorinated 
and eventually fluorinated copolymers. The degree of fluorine content within copolymers 
gives tunable structure-property relationships leading to novel materials as reported 
extensively in the literature.9-16 
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 Among fluorinated materials, fluorinated and perfluorinated elastomers, have 
been extensively used in many common industries,5 but have found their place more 
recently in current scientific research.17-23 Advancing research and technologies in 
imprint lithography,23 soft, solvent-resistant microfluidic devices,21, 22 high surface area 
proton exchange membranes,20, 24, 25 and drug delivery17 are a few examples utilizing 
fluoroelastomers. Nano- and biotechnologies are exploiting perfluoroelastomers by 
enabling a novel drug delivery platform, PRINT,17 that may offer viable solutions in 
personalized medicine. Traditional elastomer synthesis suffers from processing and 
environmental challenges.  The PRINT technology offers an alternative to overcome 
some of these hurdles. The synthetic aims described in Chapter 2 combine traditional 
methods of fluoroelastomer synthesis with an unconventional technique to develop new 
fluoroelastomers overcoming the effects of the environmental impacts previously 
endured. Similar materials are employed to scale-up the fabrication of novel shape- and 
size-specific synthetic and biological drug delivery vehicles for cancer treatment (Chapter 
3). The methodology developing the PRINT technology creating the platform and the 
first accounts of nano-molding of monodisperse, shape and size- specific protein particles 
is presented in Chapter 4.26  
 
 1.2 Fluorinated Elastomers. Fluoroelastomers are a special class of fluorinated 
polymers that exhibit a unique combination of high chemical, thermal and electric 
stabilities, non-flammability, inertness to solvents, hydrocarbons, acids and alkalis, low 
refractivity index, low surface energy, gas permeability, and oxidation and ageing 
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resistance.5 Fluoroelastomers are remarkable materials, suitable for use in particularly 
aggressive and demanding applications.  
 Fluoroelastomers exhibit unsurpassed thermal and chemical stability due to the 
abundance of fluorine atoms in the carbon backbone. The excellent oxidative resistance 
in perfluorinated elastomers exists in part due to the lack of weaker C-H bonds on the 
polymer backbone.5 Their stability is attributed to steric hindrance due to the presence of 
fluorine and stronger van der Waals forces between hydrogen and fluorine atoms present 
within the macromolecules (when applicable).27 The elasticity is derived from low 
crystallinity, low glass transition temperatures (Tgs), and an amorphous morphology. 
Fluorinated elastomers have realized great strides in improving soft lab-on-a-chip 
microfluidic devices21, 22 that are solvent resistant and could be utilized in analytical 
separations, biowarefare detections, and fast synthesis of positron emission tomography 
imaging agent. However, the advantages in morphology and solvent resistance are 
overshadowed by the synthetic challenges and difficulty in traditional curing and 
crosslinking.  
 Currently, the most relevant and commercially available fluoroelastomers are 
either comprised mostly of vinylidene fluoride (VF2) or tetrafluoroethylene (TFE).28 
Homopolymers of VF2 or TFE are semicrystalline rendering them insoluble in many 
organic solvents and unable to be melt processed. However, the introduction of a 
comonomer disrupts the polymer crystallinity and systematically alters the polymer 
properties. The copolymerization changes the symmetry of the polymer backbone, 
affecting both intramolecular and intermolecular forces. Properties such as melting point, 
glass transition temperature, crystallinity, stability, permeability, elasticity, and chemical 
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reactivity may be regulated within wide limits by introducing comonomers. The 
systematic variation of polymer composition allows for structure-property relationship 
investigations.  
 Common comonomers for VF2 systems include hexaflouropropylene (HFP), 1-
hydropentafluoropropylene (HPFP), and chlorotrifluoroethylene (CTFE).2, 3, 5, 15, 29 For 
special applications monomers such as perfluoroalkyl vinyl ethers are also incorporated. 
These are typically used in TFE-based elastomer systems.2, 3, 5, 15, 29 As noted, properties 
of the elastomers are directly related to the fluorine content; elastomers containing 
between 62-70 wt% fluorine have remarkable resistance to solvents, chemicals, flames, 
and against oxidative attack.1-3, 7, 27 Compositions with higher fluorine content are 
achievable depending on monomer selection, which in turn is chosen for its suitability to 
a given application. Less traditional materials have emerged in recent years containing 
fluoro-phosphazenes7 and fluoro- silicones4, 7, 30 presenting even more complex 
topologies.7 The research discussed in Chapter 2 relies primarily on traditionally based 
materials, but applies those chemistries to a novel synthetic methodology. 
 
 1.2.1 Fluoroelastomers from Tetrafluoroethylene. Due to the crystalline nature 
of the (PTFE) homopolymer, comonomers are employed to aid in its processibility.2, 3, 28, 
31-37 It has been shown in the literature that propylene and TFE can be readily 
copolymerized in a nearly alternating manner to give a fluoroelastomer.33-35, 37-46 
Fluorinated alkenes (such as TFE) are electron withdrawing olefins and react easily with 
electron donating monomers like propylene. This donor-acceptor copolymerization can 
also be achieved using TFE with ethylene or vinyl ether monomers.47, 48 
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Copoylmerization with ethylene leads to a highly crystalline material rendering itself less 
useful for elastomeric applications without the incorporation of additional comomers 
such as a fluorinated vinyl ether or a cure site monomer (CSM). Tetrafluoroethylene-
containing polymers are typically prepared by emulsion polymerization34, 35 using salts of 
perfluorooctanoic or perfluorononanoic acids as the surfactant to enable 
thermodynamically stable emulsions. A modified persulfate redox system39 (typically an 
ammonium persulfate) initiates polymerization.2, 3 With a stable emulsion polymerization 
system, high molecular weight copolymers are synthesized at or close to room 
temperature. At higher temperatures, the risk of chain transfer to monomers can occur.49-
55 Copolymerizations of TFE often contain unwanted side reactions such as hydrogen 
abstraction from monomer or initiator due to its extreme reactivity. With significant chain 
transfer reactions, the yielded product is limited to low molecular weight. Asahi Glass 
developed a preferred polymerization system containing TFE and propylene resulting in 
high molecular weight polymers, but not without the need for additional co-reagents in 
their redox systems.5 It should be noted that handling TFE and conducting 
polymerizations thereof demands special care, as TFE can react extremely violently, and 
the utmost caution should be exercised with TFE especially in avoiding auto-acceleration 
effects during polymerization.  
 Elastomers of p(TFE/PP) are cured based on the presence of hydrogen atoms in 
the backbone of these copolymers stemming from the propylene moiety. It was found that 
under high temperatures unsaturated sites in the backbone will form, leading to facile 
curing using peroxides and radical traps.27 Radical traps are compounds with a high 
avidity for free radical species and in this context contain vinyl groups and functions as a 
8 
crosslinker. In addition to high temperature curing, these copolymers can also p(VF2/PP) 
be crosslinked by high-energy radiation at room temperature, accompanied by the release 
of hydrofluoric acid (HF).2, 3, 38, 44, 45 Safer cure systems have been employed offering 
similar tensile strength compared to VF2 based systems (further discussion to follow in 
VF2-based elastomer sections). Subsequent to curing, the materials showed superior 
resistance to acids and bases. Nevertheless, these elastomers were outperformed in 
compression set resistance, low-temperature properties, and resistance to aromatic 
solvents by materials containing less hydrogen. Studies of TFE copolymers and their 
properties provide significant contributions to fluoroelastomer technologies, but the 
abundant presence of hydrogen in the polymer undoubtedly leaves these materials 
vulnerable to chemical or thermal degradation.5 A significant contribution to the field of 
perfluorinated elastomers56 came from copolymers of TFE and prefluoro methyl vinyl 
ether (PMVE). The discovery at DuPont lead to an “elastomeric Teflon” that is resistant 
to the most hostile environments, and is referred to by the trade name, Kalrez®.  Such 
materials will be discussed in greater depth in Chapter 3.   
 
1.2.2 Fluoroelastomers from Vinylidene Fluoride. For investigating materials 
synthesized under better control with respect to reaction kinetics and better processing 
properties, VF2-based systems are the preferred materials. Poly(vinylidene fluoride) 
materials exhibit very interesting piezo-, pyro-, and ferro-electrical properties.57-61 These 
homopolymers are inert to many solvents, oils, and acids and hence provide desirable 
base materials within the field of fluoroelastomers. Similar to PTFE, homopolymers of 
VF2 are semicrystalline and require a comonomer in order to reduce the crystallinity and 
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form an amorphous elastomer. Fluoroelastomers containing VF2 traditionally use 
hexafluoro propylene (HFP) as a comonomer to make the copolymer amorphous. The 
copolymerization proceeds essentially in an alternating manner when both monomers are 
charged in similar ratios. Steric effects are likely to prevent homopropagation of HFP. 
The cure site in VF2/HFP copolymers are the hydrogen atoms of VF2 that are flanked on 
either side by HFP units.28 These hydrogen atoms in such an environment are acidic and 
thus susceptible to abstraction. Scheme 1-1 illustrates the general reaction of base attack 
on the -CH2- creating an unsaturated site. Later generations of the VF2-based elastomers 
incorporated TFE as an additional comonomer. More recent efforts to improve solvent 
resistance by increasing the fluorine content was achieved by modifying the charge ratio 
of the monomers and including the addition of a CSM such as bromotrifluoroethylene. 
Further advances in this area integrated perfluoroalkyl vinyl ethers to afford better low 
temperature properties. These VF2-based elastomers possess outstanding resistance to 
flames, chemicals, solvents, heat, and oxidation.5 Bisnucleophiles such as bisphenols or 
diamines facilitate curing of these materials but afford poor retention of physical 
properties while peroxide-assisted crosslinking leads to enhanced properties in the 
presence of a CSM. 
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Scheme 1-1. Base Attack on Vinylidene Fluoride/Hexafluoropropylene Copolymers 
Leading to Unsaturation. 
 
A crosslinking mechanism utilizing peroxides is facilitated by the incorporation of 
a CSM such as brominated vinyl ethers into the backbone in the presence of a radical 
trap. For terpolymer systems composed of VF2, HFP, and perfluoro alkyl vinyl ether 
(RfVE) reactivity challenges may present themselves as RfVE monomers do not readily 
homopolymerize similarly to HFP, and slow relative reactivity ratios to TFE may dampen 
these systems depending on the amount of RfVE charged to the system. In the case of 
RfVE especially, increased reaction temperatures may lead to better reaction kinetics and 
faster polymerization rates, but also produce undesired carboxylic acid or acid fluoride 
endgroups.62 The addition of TFE in VF2-based systems increases the thermal stability at 
higher temperatures, but at the cost of poor low temperature properties.  
Vinylidene fluoride-based polymers are also traditionally synthesized in aqueous 
emulsions.63 Similar to TFE emulsions, perfluorooctonic acid analogues serve as 
surfactants to produce a stable emulsion. As describe previously, ammonium persulfate 
salts typically act as initiators in these systems resulting in ionic end groups. Though 
ionic end groups are predominant in this case, non-ionic end groups are achievable with 
chain transfer reactions,2, 3, 5 or by disproportionation reactions terminating the 
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polymerization. Often, buffers need to be added to the reaction to improve the stability of 
the emulsion. The resulting emulsions are coagulated by the addition of electrolytes, 
which are specifically selected depending on the desired product and the stability of the 
emulsion. The least stable emulsions may coagulate by shear as well. Subsequent to 
coagulation, the precipitated polymer is washed numerous times with water and dried in 
an oven, resulting in the generation of an aqueous waste stream and an energy intensive 
drying step.27   
Special elastomer applications may require compositions that include fluorinated 
vinyl ethers that may or may not act as a CSM. As previously eluded to, it is ordinarily 
very difficult to homopolymerize RfVE to high conversion due to their low reactivity to 
homopropagation and steric hindrance. Co- and terpolymerization on the other hand, is 
generally very attainable.  Copolymers of VF2 and RfVE have been successfully 
synthesized in molar ratios between 19:1 and 1:1. Terpolymers of VF2/TFE/RfVE have 
also been synthesized in molar ratios ranging from 1:1:1 to 2:1:2.27 
As previously discussed, TFE and VF2- based elastomers traditionally are created 
by radical polymerization to high molecular weight and subsequent curing, resulting in a 
flexible network. Some copolymers contain elastomeric properties having a linear 
topology without any additional curing steps. Fluorelastomeric behavior is enhanced, or 
in some cases can only be attained as a crosslinked network. (By definition, elastomer 
properties are achieved by creating an amorphous material, having a low glass transition 
temperature (typically below room temperature), and optimally contains a crosslinked 
network.1-3) A network is attained with reversible, physical crosslinks (thermoplastic), 
with microstructure phase separation creating anchoring islands such as with A-B-A 
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triblock copolymers with glassy A and amorphous B blocks. A more robust, irreversible 
network can be achieved through chemical crosslinks (i.e. thermoset- covalent bonds 
forming the three-dimensional network). In either case, only certain monomer 
compositions will produce crosslinked systems, as described for TFE and VF2 containing 
elastomers.  
 
1.3 Curing Fluoroelastomers. Most chemically and mechanically robust 
fluoroelastomers are thermosets, and as such the implementation of chemical crosslinks 
should ideally enhance mechanical strength, result in the ability for complete strain 
recovery, avoid occurrence of a large permanent sets when under stress, endure large 
stresses and strains, and should not introduce any sites for potential oxidative stress or 
degradation6. In traditional systems, two general classes of fluoroelastomers exist: those 
from ionic curing and those from radical curing. Within ionic cure systems,64 the most 
commonly used are amino systems or bisphenol crosslinkers. In either case, the hydrogen 
atoms of the VF2 monomers are sites of interest as their electronic properties can be 
exploited due to the two -CF2- groups on either side making the hydrogen atoms acidic 
and prone to extraction.  The polymer structure and the strength of the crosslinks are very 
important in establishing the physical properties of the elastomer.5  
Radical curing is carried out typically under radiation or with the thermal 
degradation of a peroxide free radical initiator. Though abstraction of hydrogen atoms 
from the polymer backbone can lead to successful crosslinking, this type of cure 
chemistry excels with a cure site monomer or a radically labile functional group 
incorporated into the polymer backbone in order to assist in constructing a three 
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dimensional network and is better facilitated in the presence of a radical trap (crosslinker) 
in the cure step. 
 
1.3.1 Ionic Curing: Amines, Diamines and Diaminecarbamates. Elastomers 
were originally cured using diamine65 and polyamine nucleophiles.5 The mechanism of 
crosslinking involves the initial removal of hydrogen fluoride (HF) from the VF2 
segments, generating highly polarized -CH=CF- units. These are susceptible to Michael 
addition by diamines (or polyamines) forming a highly crosslinked network.66 An 
accelerator or phase transfer catalyst, typically MgO, helps diffusion of the base into the 
material. Prior to addition to the double bond, the bonds are shifted with an allylic 
fluorine ion shift, producing a new double bond. Scheme 1-1 illustrates the ionic reaction 
mechanism described herein. Aliphatic amines and polyamines were the first in use for 
this type of curing, but due to intense reactivity associated with these compounds, less 
reactive Schiff bases were substituted. However they, too, were soon replaced by 
bisphenol curing agents, due to processing difficulties and poor retention of physical 
properties at high temperatures from the chemically weaker crosslinks.28 Volatiles, 
including HF, were emitted during the crosslinking reaction resulting in undesirable 
porous products. 
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Scheme 1-2. Curing Vinylidene Fluoride-Based Elastomers Using Diamines. 
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1.3.2 Ionic Curing with Bisphenol Systems. Bisphenol nucleophiles are still 
largely utilized in curing VF2 based elastomers.5 The overall mechanism is quite similar 
to the diamine mechanism.  These crosslinkers react only in the presence of a 
phosphonium or ammonium salt in combination with a metal compound, acting as an 
accelerator. The metal salt reacts with the bisphenol to produce a strong base 
intermediate, which can abstract hydrogen fluoride from the polymer backbone. In 
special structural sequences the double bond formed from HF abstraction can shift, which 
allows for another molecule of HF to be abstracted, resulting in a diene. Establishing 
unsaturated sites in the polymer backbone is the rate determining step in these ionic cure 
reactions.  Substitution of fluorine atoms at the double bonds with the strong base 
phenolate compounds results in crosslinking. Due to its ensuing properties, 2,2’-
bis(hydroxyphenyl) hexafluoropropane, bisphenol AF, is commonly used as the bis-
nucleophile. Copolymers containing fluorinated alkyl vinyl ethers are typically not cured 
using this system as the substitution reaction would yield a loss of trifluoromethoxide 
which further degrades to HF and carbon dioxide.5 Consequently, the elastomer is left 
with excessive porosity due to the released volatiles and sharply decreased physical and 
mechanical properties. Even without the presence of RfVEs in the polymer backbone, the 
bisphenol cure systems introduce weak junctions in the material which are susceptible to 
further nucleophilic attack by basic compounds as the crosslinking mechanism produces 
more unsaturated sites than are needed for complete curing. These undesirable weak 
points illustrate one of the major drawbacks for these cure systems.  
Radical cure systems serve as a great alternative to help mitigate some of the 
weaknesses seen in the ionic bisphenol cure systems. These radical cure systems are able 
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to improve the processability resulting in faster and more facile conversion of the 
polymer into a stable, chemically crosslinked elastomeric material. 
  
1.3.3 Radical Curing. 
1.3.3.1 Radical Curing: Peroxides. Current industrial processes rely on the 
curing of functionalized fluoroelastomers using peroxides66. Unlike the ionic cure 
mechanism, this chemistry utilizes a radical mechanism, the first step consisting of the 
thermal decomposition of a peroxide. The peroxide decomposition provides a free radical 
that can abstract a hydrogen or methylene group on the polymer backbone, creating a 
polymeric radical. The polymeric radical can then react directly or through an 
intermediate using a radical trap to form crosslinks. Another approach involves 
incorporating a functionalized branchpoint into the polymer by copolymerizing in the 
presence of a cure site monomer (CSM). The CSM contains a highly reactive group (such 
as bromine or iodine) susceptible to radical attack, and thus facilitating the crosslinking 
process.5 Scheme 1-3 illustrates a summary of the free radical crosslinking mechanism 
via a peroxide and radical trap.27  
A radical trap such as triallyl isocyanurate (TAIC) provides stable properties. 
Other radical traps may be more suitable for a given application. Typical compositions 
include zero to five weight percent of the radical trap to the polymer, while the peroxide 
is utilized in a range at or under six weight percent.5 A basic metal oxide (acid acceptor) 
and filler may be added to the cure mixture to enhance physical and thermal properties of 
the fluoroelastomer.5 As previously mentioned a bromine or iodine containing CSM can 
be incorporated into the polymer backbone during polymerization and is susceptible to 
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free-radical attack during the curing steps. (Though the polymerization of these materials 
undergoes a radical mechanism, the propensity for chain propagation is far greater than 
halogen abstraction; hence most halogenated monomer remains intact during 
polymerization.) Some common brominated CSMs include bromotrifluoroethylene, 1-
bromo-2,2’-difluoroethylene, and perfluoro(2-bromoethyl vinyl ether), the latter also 
improving low temperature properties. The introduction of iodine-containing 
fluoroelastomers, though synthetically more challenging, facilitates injection molding 
considerably. In either case, the radical produced from the thermal decomposition of the 
initiator may abstract a halogen from the polymer or add to the radical trap. This latter 
reaction is favored as it generates a more stable radical. In turn, the radical intermediate 
likely abstracts a halogen from the polymer, producing a polymeric radical. The driving 
force for such a reaction is in the transfer of the halogen from the electron poor 
fluoropolymer to the electron rich hydrocarbon of the radical trap. As these steps are 
repeated, they afford a three dimensional network.  
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Scheme 1-3. Proposed Radical Crosslinking Mechanism Using a Bromine-Containing 
CSM and a Peroxide/ TAIC System.  
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 1.3.3.2 Radical Curing: Radiation. High energy gamma radiation is another 
means of crosslinking VF2 containing fluoropolymers or poly(TFE/propylene) systems.5, 
62, 67-69 The mechanism emulates that of peroxide curing. Upon irradiation, hydrogen 
containing polymers produce polymeric radicals. The presence of a radical trap improves 
curing efficiency. In the absence of a radical trap polymeric radicals tend to combine, 
creating a relatively inert material to chemical and oxidative attack with good resistance 
to heat aging.5 To accelerate the radiation process, sensitizers such as vinyl ethynyl 
phenylol resins are added, though they are not crucial for property attainment. The lack of 
impurities from added fillers and chemicals comprises the main advantage of radiation 
curing. 
   
1.3.3.3 Radical Curing: Photoinitiators. More recently, progress has been made 
in the curing of functionalized fluoroelastomers using photoinitiators and ultraviolet (UV) 
light.70, 71 In this system, rather than the reaction being initiated thermally, as with 
peroxide initiators, free radicals are produced by photo-irradiation using UV light. 
Though conventional fluoropolymer technology does not readily utilize UV processes, 
more attention is being given to this field in academic research laboratories. The use of 
UV irradiation mitigates large shrinkage effects that are typically present in thermally 
cured systems. In a radical crosslinking mechanism, the efficiency of crosslinking is 
dependent on the reactivity of the cure site monomer in the functionalized polymer chain. 
The initial source of the radicals is not of much concern as long as the reactivity is such 
that it will abstract an atom either from the polymer backbone or from a radical trap when 
present.  
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 1.3.4 Current State-of-the-Art Elastomer Processing. Currently, commercially 
available fluorinated elastomers still face major challenges in synthesis and processing. 
The manufacturing costs are high due to multiple step synthesis, high monomer costs, 
high number of coreagents needed, and relatively high reaction temperatures and times. 
Poor reactivity of reagents and processing difficulties due to very high molecular weights 
of the polymers5 present additional difficulties.  
 
1.3.4.1 Mixing, Milling, and Molding: Challenges. Since most conventional 
fluoroelastomers are high molecular weight polymers prior to crosslinking, processing 
these materials by mixing and molding prior to curing can prove challenging owning to 
their high viscosity at room temperature. The flow characteristics are paramount in 
determining what type of processing methods will be chosen and whether the addition of 
facilitating reagents is needed. Mixing techniques focus on avoiding contamination, 
minimizing exposure to water, and maximizing energy input. Use of open milling 
requires skilled operators, results in limited productivity, and incurs environmental 
contamination. Though the process is simple, long standing times are needed to ensure an 
even distribution of fillers and coreagents. Even under the most optimal circumstances 
open milling does not offer much control.  
An internal mixer can shorten mixing times. However, these systems, also 
referred to as Banbury mixing,5, 72 require intensive cooling units and low starting 
temperatures due to the massive heat buildup that results from the viscous shearing and 
low elongation at break of the fluoropolymer. Molding, however, is the most common 
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processing procedure implemented in the elastomer industry. Standard technologies in 
compression, transfer, injection molding, extrusion, and calendaring are applicable for 
fluoroelastomers. Mold designs need to take potential shrinkage into account as some 
materials can have up to three percent size reduction in size. Even modest capital 
investments in presses and instrumentation are not always sufficient. Due to their 
inherent viscosity some procedures (i.e. injection molding) are difficult at best and often 
require the addition of low molecular weight polyethylene and mold release agents for 
successful processing. 
 
1.3.4.2 Post-Cure. The best properties are obtained in a two step vulcanizing 
process.5, 73 In the first step, referred to as compression molding, both heat, typically 
between 150 to 180 °C, and pressure, around 10 to 30 psi, are utilized to mold a sample 
in a press. The second step is often referred to as the post-cure step and consists of heat 
(200 – 250 °C) in air at atmospheric pressure for 12-24 hours. This approach ensures 
optimal physical properties. The specific mechanism that affords these improved 
properties is not well understood but it is known that an increased degree of crosslinking 
is observed.5 It has been suggested that bonds are formed from a Diels-Alder type 
reaction between neighboring unsaturated, dehydrofluorinated units. The post-cure step 
also allows volatile side products such as HF and water to escape. Though from a 
materials composition perspective, isolating the elastomer from unsafe biproducts such as 
HF is advantageous, but also increases the shrinkage of the final product. The increased 
crosslinking resulting from the post cure contributes to additional shrinkage introducing a 
serious problem for fluoropolymers. 
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1.3.4.3 Liquid Precursor Approach. As previously discussed, the primary 
objective in elastomer research is to obtain an amorphous material with a low Tg and 
desirable mechanical properties. Present benchmark materials are high in molecular 
weight and undergo chemical crosslinking to increase performance. High molecular 
weight fluorinated and perfluorinated polymers face processing and molding challenges 
due to their thermal stabilities and solvent resistance already present in the un-cured state, 
especially for those of TFE analogues. The next generation of fluoroelastomers faces 
some challenges such as reactivity of the reagents, cost, overall reaction kinetics, 
environmental impacts, and functionality to enable the exploitation of their properties that 
are already technologically advanced.  
Though the level of chemical inertness of perfluoroelastomers surpasses VF2-
based elastomers, progress is being made to improve the crosslinking conditions through 
the incorporation of co-reagents and creating facile post-cure methods for the fabrication 
of stable elastomer materials.5 As outlined in the previous sections above, ionic curing 
involves using co-reagents to facilitate nucleophilic attack on the polymer backbone with 
loss of hydrofluoric acid. This method faces many processing difficulties and creates 
relatively poor retention of physical properties. High molecular weight polymers that are 
crosslinked using a free radical approach in conjunction with a CSM integrated into the 
backbone endure processing challenges as well but are an easier approach to curing than 
ionic systems. A more cost effective, facile approach in developing new fluorinated 
elastomers in a few simple steps that are environmentally friendly has yet to be met. 
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The approach developed for the next generation materials is simple and 
obtainable by modifying certain key parameters from some already well established 
methods. A VF2 based platform with a CSM incorporated into its backbone for radical 
curing was chosen due to the challenges and disadvantages of the other systems 
mentioned above. A brominated vinyl ether CSM was chosen for its low temperature 
properties. Perfluoro(2-bromoethyl vinyl ether) (EVEBr), as do other fluorinated vinyl 
ethers, readily polymerize with VF2.  The incorporation of functional comonomers to 
enable facile crosslinking and to break up the crystallinity is essential for fluoroelastomer 
technology. Additional comonomers were investigated for studying structure-property 
relationships. 
One way to make the curing steps and processing easier is to synthesize low 
molecular weight oligmers in exchange for current high molecular weight 
fluoropolymers. The synthesis of fluorinated oligomers has recently been emerging in the 
literature. Research in polymerizing telomers74-94 and oligomers,4, 95-97 iodine transfer 
reactions,98-101 and fluorotelechelic macrodiols102-111 with subsequent crosslinking has 
been studied. Low viscosity oligomers will not present processing challenges and upon 
curing into mechanically and chemically robust materials circumvents the need for fillers, 
accelerators, sensitzers, phase transfer catalysts, and other coreagents.  In contrast to high 
molecular weight polymers, low molecular weight functional oligomers are liquids at 
room temperature and present immense utility. Such liquids can take on any shape and 
when containing a cure site monomer (CSM) or other functionality, can subsequently be 
crosslinked to form a chemically and mechanically robust, solid material. Liquid 
macromolecular precursors have recently drawn much attention for novel applications 
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such as soft microfluidic devices,22 soft lithographic capabilities19, 23 and particle 
replication,17 which will be further discussed in Chapters 3 and 4. Thermal or 
photochemical crosslinking of liquid precursors into solids has created new pathways to 
facilitate quick production of devices and other soft materials.  
Additionally, most fluorinated elastomers are prepared by free radical emulsion 
polymerization using fluorinated surfactants and modified persulfate initiator systems.27 
However, the use of fluorinated surfactants is becoming obsolete. A class of fluorinated 
surfactants commonly identified as C-8’s, stemming from fluorinated octanoic acid has 
been widely used to form stable emulsion polymerizations of PTFE in aqueous media. 
Octanoic acid was recently discovered to be a biopersistant compound, thus forcing the 
EPA into an investigation and subsequently banning this class of fluorinated 
surfactants112.  A solution polymerization process for synthesizing fluoropolymers is not 
encouraged nor well accepted as fluorinated solvents are even less environmentally 
friendly than traditional organic solvents. This creates challenges to design materials with 
outstanding properties without harming the environment.   
 In attempts to overcome the many challenges in developing new and improved 
fluorinated elastomers, the research described herein focuses on developing a facile, 
environmentally friendly synthesis of a fluorinated oligomeric precursor in supercritical 
carbon dioxide is proposed. As a green solvent, carbon dioxide enables the safe handling 
of even the reactive monomer, TFE. These perpolymers could be subsequently cured into 
a stable fluoroelastomer utilizing free radical crosslink chemistry that is well established 
in this industry. By starting with an oligomeric, liquid precursor, one improves 
processability and can mold the elastomers to any size and shape for customized 
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application realization. The utilization of crosslinking low molecular weight, liquid 
macromolecules will exploit facile fabrication of fluorinatated elastomers in efforts to 
improve physical properties.  
The polymerization of oligomers composed of VF2 and/or TFE, along with a cure 
site monomer will be focused upon. Photochemical crosslinking facilitates fast and easy 
processing into solid elastomers and circumvents the shrinkage often resulting from 
thermal cure steps. This strategy can be employed to pattern or mold a substrate upon 
curing, and henceforth various applications can be realized, including microfluidics, 
high-surface area proton exchange membranes, and specialty coatings. By optimizing 
reaction conditions of the polymer synthesis and of the cure chemistry, efforts to tailor 
the physical and chemical properties of these materials for improved performance are 
investigated. 
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CHAPTER 2 
 
 
 
 
 
 
 
 
 
NEW FLUORINATED LIQUID OLIGOMERS SYNTHESIZED IN 
SUPERCRITICAL CARBON DIOXIDE AND THEIR USE AS ELASTOMERS
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2.0 Introduction. 
2.1 Synthesis of Fluorinated Polymers in Supercritical Carbon Dioxide. 
2.1.1 Background on Carbon Dioxide as a Reaction Medium. Carbon dioxide 
(CO2) as a reaction medium is a sustainable platform for the polymerization of many 
organic monomers and particularly for fluorinated monomers.  Interest in the use of 
supercritical scCO2 as a reaction medium and a green solvent has become ever 
increasing. DeSimone and coworkers have pioneered much of the work using scCO2 as a 
continuous phase in the synthesis of multiple traditional hydrocarbon based polymers 
including poly(methyl methacylate),1-5 polystyrene,6, 7 and poly(acrylic acid)8-10 to name 
a few. Fluorinated monomers are readily soluble in CO2 and the exploitation as a green 
solvent for the polymerization of fluoropolymers started in the early 1990’s.11 As a 
reaction medium, scCO2 brings many benefits to the table. Using CO2 for fluoropolymer 
synthesis instead of traditional fluorinated or organic solvents or even aqueous based 
systems affords an environmentally friendly approach that mitigates the use of 
fluorinated surfactants and the generation of large quantities of halogenated, organic, or 
aqueous waste. Additionally, aqueous suspension or dispersion methods result in 
increased occurrence of carboxylic acid endgroups that are deleterious to the products’ 
function. Other advantages include its tunability as a solvent in the supercritical range, 
having gas-like densities and liquid-like viscosities. For many polymers carbon dioxide 
can also act as a plasticizing or foaming agent. Along with its environmental advantages, 
energy intensive drying steps are mitigated when using CO2 as it has a low heat of 
vaporization thus reducing cost, and in most cases resulting in ready to use, dry products 
upon venting.  
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The first report of CO2 utilized in the synthesis of fluoropolymers was by 
DeSimone and coworkers11. Since then a number of different systems have been 
investigated including the synthesis of tetrafluoroethylene-based copolymers12-14 with 
monomers such as perfluoropropyl vinyl ether (PPVE),14 hexafluoropropylene (HFP),13 
and 2,2-bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole (PDD)15, 16 as well as vinylidene 
fluoride-based fluoropolymers.17-21 The teleromerization of tetrafluoroethylene (TFE) 
was also described by Romack and coworkers.22 Much work has been invested in 
studying vinylidene fluoride (VF2) and HFP copolymerizations as batch reactions23 and 
continuous polymerization processes.24, 25 Ahmed and coworkers found that VF2/HFP 
copolymers synthesized in CO2 possess similar properties to analogous materials 
synthesized using more conventional systems.18, 23, 24 
Fluorinated elastomer synthesis in CO2 is of particular interest due to the 
solubility of fluorinated monomers in scCO2. The synthesis of materials ranging from 
thermally resistant, high molecular weight fluoropolymers to solvent resistant 
fluoroelastomers in scCO2 has created an opportunity for cleaner processes and cost 
reduction, not to mention safety risk reduction.13, 18, 23, 24, 26 Handling TFE as a 50 wt.-% 
mixture in CO2 enables safer management of this most reactive monomer, that is very 
exothermic when polymerized. Additionally, chain transfer reactions to solvent are not of 
concern when using CO2 as a polymerization medium. Furthermore, low temperature 
polymerizations are possible in CO2 which affords the ability to minimize unwanted side 
reactions that could lead to early termination or acid chain end groups that are thought to 
be involved in the material’s degradation.27, 28 Increased polymerization temperatures 
ranging between 70 and 95 °C result in a β-scission side reaction in the presence of alkyl 
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vinyl ethers, which can lead to undesired acid fluoride and carboxylic acid end groups 
(Scheme 2-1).27, 28 The synthesis of fluorinated, liquid prepolymers, their 
characterization, and conversion into solid, solvent resistant elastomers are discussed. 
Crosslinked elastomers and their properties were investigated using a facile ultra violet 
(UV) curing approach with a well-established radical cure site monomer (CSM)/ radical 
trap initiator.  
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Scheme 2-1. Beta-scission reaction of fluorinated vinyl ethers during polymerization. 
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2.2 Synthesis of Novel Fluorinated, Liquid Macromolecules in Supercritical Carbon 
Dioxide. 
 2.2.1 Materials. TFE was obtained by DuPont as a 50 wt-% mixture in CO2 and 
used as received. 2-Bromotetrafluoroethyl trifluorovinyl ether (EVEBr) was obtained 
from Matrix Scientific and was used as received. α,α,α-Trifluorotoluene, sodium chloride 
(NaCl), potassium hydroxide (KOH), and hydrogen peroxide, 30wt% (H2O2) was 
obtained from Aldrich and used as received. Vinylidene fluoride was obtained from 
Synquest and used as received. SFC purity CO2 was obtained from Air Products. Di-(2-
ethylhexyl)peroxydicarbonate (EHPDC) was obtained from Arkema Inc. and used as 
received. Bis(perfluoro-2-N-propoxypropionyl) peroxide (HFPO dimmer peroxide) was 
prepared in 1,1,2-trichloro-1,2,2-trifluoroethane (Freon® 113), according to a published 
procedure.29  
 
2.2.2 Instrumentation. Infrared spectra were collected using a BIO-RAD FTS-7 
spectrometer. Proton and fluorine NMR spectra were acquired in deuterated acetone 
using a Varian Unity Inova 600 NMR spectrometer.  Thermogravimetric analysis was 
carried out using Perkin Pyris 1 TGA with a heating rate of 10 °C/min in a constant 
nitrogen purge. Glass transitions and melting points were measured with a Seiko 220C 
differential scanning calorimeter, using heating rates of 10 °C/min and 20 °C/min for the 
first and second heat respectively, and 100 °C/min as the cooling rate. Glass transitions 
were determined at the inflection point of the endotherm and melting points were 
determined at the peak of the endotherm. Molecular weights, relative to narrow 
polystyrene standards, were measured using a Waters GPC system with a Wyatt Optilab 
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DSP interferometric refractometer and a Wyatt Dawn EOS as the detectors. The 
measurements were taken at 25 °C with tetrahydrofuran as the mobile phase on three 
columns (Waters Stygel HR0.5, HR2, HR4, HR5). Elemental Analysis was performed by 
Atlantic Microlab, Inc. Photochemical crosslinking was conducted in an ELC-500 Light 
Exposure System equipped with an ultra-violet light source (UVA 365 nm). Mechanical 
property measurements were conducted using an Instron 5566 at a crosshead speed of 20 
mm/min at 25 °C. The Young’s modulus was calculated using the initial linear portion of 
the stress/strain curve (0 – 5 % strain). Static contact angles on cured polymer samples 
were measured using a KSV Instrument LTD CAM 200 Optical Contact Angle Meter. A 
screw-top syringe (Fisher) was used to deposit a liquid drop onto the flat polymer 
surface. Distilled water and diiodomethane were used as testing liquids and their surface 
tension properties are summarized in Table 2-8. The angles reported herein are the 
averages of at least four measurements. Scanning electron microscopy was performed on 
a Hitachi S-4700 SEM. 
 
 2.2.3 Synthesis of HFPO Dimer Peroxide.  The HFPO dimer peroxide was 
synthesized in Freon 113 as previously reported.29 Briefly, the reaction was conducted in 
a round bottom flask in a NaCl/ ice bath, not allowing the reaction temperature to go 
above 5 ºC. The perfluorinated acid fluoride reacted with H2O2 and KOH at the organic- 
(Freon 113) water interphase to for the perfluoro acyl peroxide. The final product was 
stored in a Frein 113 solution under dry ice. The iodine titration technique, ASTM 
Method E 298-91, was utilized to determine the initiator concentration in solution. The 
overall reaction is summarized in Scheme 2-2.   
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Scheme 2-2. Synthesis of HFPO dimer peroxide. 
 
 2.2.4 Synthesis of Copolymers.  The experimental set-up is shown in Figure 2-1. 
Polymerizations were carried out in a 25 mL high-pressure reaction vessel equipped with 
a stir bar, thermocouple, rupture disk and a sapphire window which permits visual 
observation of the reaction mixture with an endoscope. In a typical reaction the high 
pressure reaction vessel was pressurized with CO2 at least three times to remove oxygen 
and leak test the vessel after which the reaction cell was purged with argon in order to 
avoid introducing air into the reaction vessel and cooled to 15 °C. Under a constant 
blanket of argon EVEBr was charged via syringe directly into the reactor. After sealing 
the cell and stopping argon purge, VF2 was introduced via a manual high pressure syringe 
pump (HIP, Model 62-6-10) under stirring. To add the desired amount of VF2 the pump 
was pressurized to 48 bar (696 psig) and the volume of the VF2 added was calculated 
from the density at 48 bar. By repeated opening and closing of the valve between the 
pump and the reaction vessel and repressurizing to 48 bar the desired volume was 
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introduced.  When applicable, TFE/CO2 mixture (50 wt.-%) was subsequently added. To 
add the desired amount of TFE, a manual high pressure syringe pump was again used. 
The pump was pressurized to 103 bar (1494 psig) with the TFE/CO2 mixture and the 
volume of the TFE/CO2 mixture added was calculated from the density at 103 bar. By 
repeated opening of the valve between the pump and the reaction vessel and 
repressurizing to 103 bar the desired volume was introduced. The reaction vessel was 
then heated to the desired reaction temperature, typically 50 °C. Initiator solution was 
transferred via syringe to a small addition tube in-line with CO2 lines under argon purge. 
The reaction view cell was then filled with CO2 using an automatic syringe pump (ISCO, 
Model 260 D) while simultaneously introducing the initiator. After the polymerization, 
the reaction vessel was cooled with a dry ice bath, and the CO2 was slowly vented. The 
reaction was visually monitored through the sapphire window using an endoscope. 
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Figure 2-1. High pressure reaction set-up. 
 
2.2.4.1 Results and Discussion of the Synthesis of p(VF2/EVEBr) and 
p(VF2/TFE/EVEBr) Elastomer Copolymers. The synthesis of new fluorinated 
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elastomers was conducted in supercritical carbon dioxide under varying reaction 
conditions. The reaction conditions strongly influence the structure-property relationship 
of the resulting products as well as their overall stability. This systematic study 
investigated the effects of initiator composition and concentration, reaction temperature, 
reaction pressure, and monomer concentration. Copolymers of VF2 and EVEBr were 
initially investigated. The incorporation of TFE was later pursued in efforts to enhance 
the thermal and chemical stability.  
All monomers discussed are soluble in scCO2.  The reaction mixture was 
homogenous throughout the polymerization for copolymers of VF2 and EVEBr under 
certain conditions. With no TFE present, the polymerizations were initially homogeneous 
but become heterogenous as the polymerization proceeded. With increasing TFE 
incorporation though, visual observations indicated a dense liquid settling on the bottom 
of the reactor. With TFE feed ratios above 50 mole % precipitation polymerization was 
observed with white solid particulates coming out of solution within the first few minutes 
after initiation. Vinylidene fluoride and EVEBr copolymers were typically isolated as 
viscous, colorless, transparent liquids; while VF2/EVEBr/TFE terpolymers were obtained 
as colorless, wax-like materials that increased in stiffness with increasing TFE content. 
When greater than 50 % of TFE was incorporated in the tepolymer, a semi-crystalline 
solid was obtained. These semi-crystalline TFE terpolymers were insoluble in 
conventional and fluorinated solvents while the amorphous VF2/EVEBr and 
VF2/EVEBr/TFE polymers were soluble in acetone, methylethylketone (MEK), α,α,α-
trifluorotoluene (TFT), and tetrahydrofuran (THF). The mole ratio of initiator charged 
ranged between five and ten percent. Fluorine and proton NMR confirmed all monomers 
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were incorporated and no residual monomer was present after isolation and drying of the 
product. A number of different variables for the scCO2 polymerization were investigated, 
including choice of thermal initiator, reaction pressure, and the feed ratio of the monomer 
components. 
 
 2.2.4.1.1 Initiator Investigation for CO2 Polymerization. When choosing a 
thermal peroxide initiator for the synthesis of fluorinated oligomer, there are many 
variables to consider such as the initiator reactivity, solubility, decomposition 
temperature, and physical state at room temperature were some of the characteristics 
pertinent for this study. Table 2-1 summarizes the initiators investigated. 
 
Table 2-1. Thermal initiator investigation used for fluorinated oligomer synthesis. 
Initiator T (t1/2 = 10hrs) [°C] 
HFPO dimer peroxide 3530 
Benzoyl peroxide and dimethyl analine redox 
system 
2531 
Di-tert-butyl-peroxide 11032 
Ethyl Hexyl Peroxy Dicarbonate 5033 
 
 
 The ten hour half life of thermal initiators was investigated (in CO2 or benzene 
depending on availability). The polymerization reaction time was desired to last at least 
two half-lives and thus chosen to be around 24 hours at the temperature of the ten hour 
half life. Di-tertbutylperoxide (tBP) has been commonly employed with VF2 
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polymerizations,34-36 however tBP has a 10 hour half life at 110 °C and it has been shown 
that when copolymerizing fluorinated vinyl ethers above 70 ºC, unwanted side reactions 
result27, 28 thus, low reaction temperatures are preferable for these polymerization 
systems. Previous studies in our lab investigated polymerizations employing a solution of 
bis(perfluoro-2-N-propoxypropionyl) peroxide in 1,1,2-trichloro-1,2,2-trifluoroethane 
(Freon® 113). The 10 hour half-life in CO2 of this HFPO dimer peroxide is 35 °C but this 
initiator proved problematic due to the high initiator volume needed to obtain low 
molecular weight oligomers. Since this initiator cannot safely be synthesized neat, the 
amount of co-solvent introduced into the reactor created a complicated co-solvent 
polymerization system that veered from a green process with the substantial addition of a 
chloro-fluoro carbon (CFC). Two reaction pressures were investigated, 138, 172, and 345 
bar. A redox system with benzoyl peroxide and dimethylanaline was attempted a number 
of times with little success but ethyl hexyl peroxy dicarbonate (EHPDC) was found to be 
a suitable thermal initiator for the successful synthesis of functional fluorinated oligomers 
at low temperatures. 
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Scheme 2-3. Synthesis of functional fluorinated oligomers in carbon dioxide. 
 
 2.2.4.1.2 Monomer Feed Ratios. Investigations of percent solids, pressure, and 
initiator concentration were conducted. Polymerization conditions are summarized in 
Tables 2-2 and 2-3. Reaction conditions were carefully varied especially in cases of 
polymerizations that included TFE due to the highly exothermic nature of its 
homopolymerization and chance of autoexcelleration. Most polymerizations reported 
herein were conducted at 20 percent solids at 345 bar and with an initiator concentration 
of 0.25 mol%. The feed ratios of the three monomers were varied. To maintain a 
proximity to conventional fluoroelastomers with respect to the amount of CSM, the feed 
ratio of EVEBr for most experiments was held constant at 15 mole %. The charged ratio 
of VF2 and TFE was varied from 0 – 85 mol%. The best results were observed for feed 
ratios close to 50/35/15 mol% of VF2/TFE/EVEBr resulting in products with good yields 
(generally above 65%) and good processability. As the feed of TFE was increased above 
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50 mole% the materials became semi-crystalline, leading to processing challenges. These 
semi-crystalline waxes were difficult to get to flow and mix with the cure components 
and hence were difficult to crosslink.     
 Copolymerizations of VF2 with EVEBr resulted in precipitation polymerizations 
where the precipitated polymer was swollen in CO2. At times the product became so 
viscous stirring was halted. As shown in the Figure 2-2, a clear liquid settles out and is 
viscous enough to arrest the stir bar (white object). The physical properties of the 
fluorinated oligomers synthesized are summarized in Tables 2-5 and 2-6. The physical 
properties show no obvious correlation between the average molecular weights and their 
thermal properties. In general with increasing molecular weight, increasing thermal 
properties are expected. The fact that no obvious trend is seen between molecular weight 
and thermal properties may be as a results from working within a relatively narrow range 
of molecular weight and due to the fact that the GPC results are calibrated from 
polystyrene standards, a very different type of material compared to the fluorinated 
oligomers. Optical images of the oligomers are illustrated in Figure 2-3. 
 
 50
 
Figure 2-2. Image of reaction vessel during vinylidene fluoride/brominated 
perfluoroethyl vinylether polymerization demonstrating precipitation of viscous polymer 
layer. 
 
    
Figure 2-3. Optical images of typical viscous functional fluorinated oligomers 
synthesized in carbon dioxide. 
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Table 2-2. Reaction conditions for copolymers composed of vinyldene fluoride and 
brominated perfluoroethyl vinylether. 
 
VF2 mol% (feed) EVEBr mol% (feed) Pressure [bar] Inititiator [mol %] 
48 (50) 52 (50) 138 tBP [2.50] 
55 (66) 45 (33) 172 HFPO [2.50] 
57 (60) 43 (40) 138 EHPDC [2.00] 
60 (66) 40 (33) 138 HFPO [2.50] 
60 (75) 40 (25) 138 EHPDC [0.50] 
61 (80) 39 (20) 345 EHPDC [0.25] 
62 (68) 38 (32) 138 EHPDC [1.00] 
63 (60) 37 (40) 172 HFPO [2.50] 
63 (63) 37 (37) 138 HFPO [2.50] 
65 (60) 35 (40) 172 HFPO [2.50] 
66 (80) 34 (20) 138 EHPDC [0.25] 
71 (75) 29 (25) 138 HFPO [2.50] 
71 (80) 29 (20) 345 EHPDC [0.25] 
73 (50) 27 (50) 138 HFPO [2.50] 
73 (60) 27 (40) 172 HFPO [2.50] 
79 (80) 21(20) 345 EHPDC [0.25] 
80 (80) 20 (20) 138 EHPDC [0.25] 
85 (50) 15 (50) 138 tBP [2.50] 
88 (66) 12 (33) 138 HFPO [2.50] 
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Table 2-3. Reaction conditions for terpolymers composed of vinylidene fluoride, 
tetrafluoroethylene, and brominated perfluoroethyl vinylether using EHPDC as the 
initiator. 
 
VF2 mol% 
(feed) 
EVEBr 
mol% (feed) 
TFE mol% 
(feed) 
Pressure 
[bar] EHPDC[mol %] 
0 (0) 10 (15) 90 (85) 345 [0.50] 
6 (35) 8 (15) 86 (50) 345 [0.25] 
21 (70) 34 (15) 45 (15) 345 [0.25] 
      24 (73)       40 (20)       36 (7) 138       [0.50] 
34 (60) 18 (15) 48 (25) 345  [0.25] 
52 (35) 12 (15) 36 (50) 345 [0.50] 
52 (73) 38 (20) 10 (7) 345 [0.50] 
64 (50) 9 (15) 27 (35) 345 [0.25] 
70 (10) 7 (15) 23 (75) 345 [0.50] 
72 (50) 7 (15) 21 (35) 345 [0.25] 
73 (50) 7 (15) 20 (35) 345 [0.25] 
76 (50) 11 (15) 13 (35) 345 [0.25] 
76 (50) 17 (15) 7 (35) 345 [0.25] 
79 (50) 12 (15) 9 (35) 345 [0.25] 
82 (50) 10 (15) 8 (35) 345 [0.25] 
 
 
2.2.4.2 Characterization. 
2.2.4.2.1 Proton and Fluorine NMR of Copolymers. Fluorine NMR spectra of 
copolymers composed of VF2 and EVEBr and terpolymers composed of VF2, EVEBr, 
and TFE demonstrated incorporation of all the monomers charged as shown in Figures 2-
4 and 2-5, respectively. Table 2-4 summarizes the assigned peaks of the spectra. The lack 
of unsaturated sites in the fluorine and the proton NMR spectra indicates that residual 
monomer was not present. The two fluorinated methylene groups of the vinyl ether side 
chain (-O-CF2-CF2-Br) integrated to the same values indicating that bromine abstraction 
did not occur during the polymerization. These methylene signals were used to calculate 
the normalized amount of EVEBr incorporated. Peaks ranging from -92 to -96 ppm and 
between -109 and -115 ppm were assigned to the fluorinated methylene –CF2- groups of 
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VF2. The integrals assigned to VF2 were used to calculate the normalized amount of VF2 
incorporated into the polymer. By difference the amount of TFE incorporated into the 
polymer was obtained in the case of terpolymers. The incorporation of TFE was 
substantially larger than the feed ratio, owing to the high reactivity of the monomer. 1H 
NMR (not shown) showed a broad peak ranging from 2.5 to 3.3 ppm corresponding to 
the -CH2- unit of VF2. 
 
 
Figure 2-4. 19F NMR spectrum of a typical p(73:27 VF2-EVEBr) copolymer. 
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Table 2-4. Peak assignment for 19F NMR spectra of synthesized co- and terpolymers. 
Shift (ppm) Designation Structure Assignment Reference 
-71, -72.5 Sharp intense multiplet -CF2-CF2Br (f) 
37 
-82, -84 Sharp intense multiplet O-CF2-CF2- (d) 
38 
-91.5 Broad multiplet -CF2-CH2-CF2-CF (a,b) 
38 
-111.5 Broad multiplet -CF2-CH2-CF2-CF (a,b) 
37 
-124 Broad multiplet -CH2-CF2-CF-O- (c) 
37 
-126 Broad multiplet -CF-CF2-CF2- (g) 38 
-130 Sharp intense multiplet -O-CF2-CF2-H (e) 
37 
-138; -144 Sharp intense multiplet 
-CF3-CFH-O-
CF2- 
(h) 39 
     
 
 
 
Figure 2-5. 19F NMR of p(82:10:8 VF2/TFE/EVEBr) terpolymer. 
 
2.2.4.2.2 Thermal Property Analysis. Thermal properties of co- and terpolymers 
were investigated by thermogravimetric analysis (TGA) and differential scanning 
calorimetry (DSC). The results for both TGA and DSC are summarized in Tables 2-5 and 
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2-6, respectively. The thermograms of these copolymers show good thermal stability as 
decomposition temperatures (onset of 5 % weight loss) range from 77 to as high as 425 
°C for the copolymers and from 232 to 389 °C for the terpolymers. Most of the 
terpolymers possess thermal stabilities above 350 °C, which is likely due to the presence 
of TFE in the polymer. A typical thermogram of a terpolymer composed of 52 mol% of 
VF2, 12 mol% of EVEBr, and 36 mol% of TFE is illustrated in Figure 2-6. As expected, 
glass transition temperatures were found to increase as the molecular weights of the 
polymers increased or for polymers with similar molecular weights as the amount of TFE 
in the composition were increased. Glass transition temperatures of the copolymers range 
from -63 to -23 °C, while the Tg’s of terpolymers range between -30 to -4 °C. As most 
oligomers were liquids at room temperature, all the Tg’s were below room temperature.  
Having low Tg’s (relative to room temperature) is also extremely beneficial and 
imperative, as these oligomers will need to retain a low Tg after crosslinking to maintain 
their elastomeric properties. Glass transition temperatures are influenced by molecular 
weight such that as the polymer molecular weight increases, so does the Tg until the 
critical molecular weight of entanglements for the polymer is reached at which point the 
Tg levels off. Glass transition temperatures are also affected by side chain mobility of the 
vinyl ether. As expected, with an increasing amount of EVEBr incorporated into the 
polymer backbone the Tg decreases. Figure 2-7 illustrates a typical thermogram of a 
copolymer composed of 55 mole% of VF2 and 45 mole% of EVEBr using DSC. 
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Table 2-5. Physical properties of copolymers. 
VF2 
[mol%]a 
EVEBr 
[mol%]a 
Mn 
[kg/mol]b 
Mw 
[kg/mol]b PDI
b Tg [ºC]c 5 % lossd 
55 (60) 45 (40) 14.2 24.9 1.8 -30 369 °C 
57 (60) 43 (40) 9.0 23.0 3.3 -59 77 °C 
60 (66) 40 (33) 8.9 16.8 1.9 -63 174 °C 
60 (75) 40 (25) 14.0 45.0 3.2 -31 375 °C 
61 (80) 39 (20) 29.0 61.0 2.1 -32 NSA 
62 (68) 38 (32) 13.0 35.0 2.7 -54 110 °C 
63 (60) 37 (40) 7.4 14.4 2.0 -37 211 °C 
63 (63) 37 (37) 6.6 12.9 1.8 -41 115 °C 
63 (60) 37 (40) 7.4 14.4 2.0 -37 211 °C 
66 (80) 34 (20) 15.0 53.0 3.5 -30 422 °C 
71 (75) 29 (25) 7.6 11.2 1.5 -56 303 °C 
71 (80) 29 (20) 31.0 112.0 3.6 -25 425 °C 
73 (50) 27 (50) 3.9 8.7 2.5 -27 273 °C 
73 (60) 27 (40) 6.2 14.1 2.3 -38 110 °C 
80 (80) 20 (20) 15.0 53.0 3.5 -30 NSA 
88 (66) 12 (33) 7.3 16.7 1.9 -37 185 °C 
a: obtained using fluorine NMR; b: obtained by using GPC; c: obtained by using DSC; d: obtained by using 
TGA; NSA: no sample available. 
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Table 2-6. Physical properties of terpolymer. 
VF2 
mol%a 
(feed) 
EVEBr 
mol%a 
(feed) 
TFE 
mol%a 
(feed) 
Mn 
[kg/mol]b 
Mw 
[kg/mol]b PDI
b Tg 
[°C]c 
5 % 
lossd 
21 (70) 34 (15) 45 (15) 41.0 129.0 3.1 -27 NSA 
24 (73) 40 (20) 36 (7) 21.0 69.0 3.3 -30 345 °C 
34 (60) 18 (15) 48 (25) 33.0 69.0 2.1 -23 375 °C 
52 (73) 38 (20) 10 (7) 25.0 100.0 3.9 -27 NSA 
52 (35) 12 (15) 36 (50) 49.0 89.0 1.8 -6 389 °C 
64 (50) 9 (15) 27 (35) 83.0 145.0 1.8 -13 367 °C 
70 (10) 7( 15) 23 (75) 63.0 107.0 1.7 -4 NSA 
72 (50) 7 (15) 21 (35) 50.0 70.0 1.4 -11 388 °C 
73 (50) 7 (15) 20 (35) 78.0 137.0 1.8 -19 385 °C 
76 (50) 11 (15) 13 (35) 50.0 118.0 2.4 -9 380 °C 
76 (50) 17 (15) 7 (35) 74.0 129.0 1.7 -21 369 °C 
79 (50) 12 (15) 9 (35) 42.0 68.0 1.6 -23 232 °C 
82 (50) 10 (15) 8 (35) 63.0 120.0 1.9 -18 384 °C 
a: obtained using fluorine NMR; b: obtained by using GPC; c: obtained by using DSC; d: obtained by using 
TGA; NSA: no sample available. 
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Figure 2-6. Thermogravimetric analysis of p(52:12:36 VF2/EVEBr/TFE) terpolymer. 
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Figure 2-7. DSC thermogram of the second heat of p(55:45 VF2/EVEBr) copolymer. 
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 2.2.4.2.3 Gel Permeation Chromatography. The fluorinated oligomers were 
soluble in THF and were analyzed using GPC. Qualitative molecular weight values were 
obtained against polystyrene standards. Results of GPC characterization is summarized in 
Tables 2-4 and 2-5 for the co- and terpolymers respectively. Number average molecular 
weights (Mn) for the copolymer of VF2 and EVEBr ranged from 3.9 to 31.00 Kg/mol 
with polydispersity indexes ranging from 1.5 to 3.5, typical for free radical 
polymerizations. Number average molecular weights of terpolymers composed of VF2, 
EVEBr, and TFE ranged from 21.0 to 83.0 Kg/mol. Polydispersity indices of the 
terpolymers ranged from 1.7 to 3.3. Some terpolymer samples were insoluble in THF due 
to high % TFE and resulting crystallinity and thus unable to be characterized using GPC.   
  
 2.2.4.3 Conclusions: Synthesis in scCO2. Co- and terpolymers of different 
compositions containing VF2, EVEBr as a cure site monomer, and at times TFE, were 
synthesized in supercritical carbon dioxide and analyzed using NMR, IR, TGA, DSC and 
GPC. The synthesis in CO2 of these fluorinated elastomers allowed for safe handling of 
TFE, was more environmentally responsible as it negated the typical generation of 
halogenated, organic, or aqueous waste, and circumvented the use of fluorinated 
surfactants. Upon venting, a dry product was isolated, decreasing the energy demand of 
the process as an energy intensive drying step is not necessary. A facile polymerization 
process for the synthesis of functionalized, fluorinated oligomers is realized using CO2. 
These liquid, functionalized, fluorinated macromolecules allow for facile processing in 
the conversion to solid elastomers.  
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2.3 Crosslinking Liquid Oligomers. 
 2.3.1 Materials. A variety of radical traps were used included triallyl 
isocyanurate (TAIC), 1,4-cyclohexane dimethanol divinyl ether (CDE), and di(acryloyl) 
piperazine (DAP). These were all obtained from Aldrich and used subsequent to 
deinhibition by flowing through a neutral alumina column. Photoinitiator including 2,2-
dimethoxy-2-phenylacetophenone (DMPA), hydroxycyclohexyl phenyl ketone (HCPK), 
2-hydroxy-2-methyl propiophenone (HMP), and diethoxyacetophenone (DEAP) were 
obtained from Sigma Aldrich and were used as received. Thermal initiators included 2,2-
azobis(2-methypropionitrile) (AIBN), benzoyl peroxide (BPO), and di(2-ethylhexyl) 
peroxy dicarbonate (EHPDC) and were also   obtained from Sigma Aldrich and used as 
received unless stated otherwise.  AIBN was recrystallized from methanol prior to use. 
 
 2.3.2 Conversion of Functional Liquid Oligomers to Solid Elastomers. The 
chemical crosslinking of fluorinated materials as discussed in Chapter 1 has been well 
established in the literature, especially in the patent literature. Cured elastomers are 
achieved by two main pathways either via an ionic or radical mechanism. The functional, 
liquid prepolymers synthesized in CO2 were to be radically crosslinked with a radical trap 
in the presence of a brominated CSM. The concentration and choice of either thermal or 
photoinitiators was investigated for facile, rapid curing. Further optimization was 
considered by varying the radical trap and its concentration.  
Liquid precursors were thoroughly cured using a radical trap and initiator. 
Triisocyanurate acted as the radical trap and (DMPA) was found to be the best 
photoinitiator based on the elastomeric mechanical properties, highest degree of 
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successful crosslinking and lowest % sol-fraction. All components were added with the 
radical trap/initiator wt-% to liquid precursor between 5:1 and 25:5. Components were 
dissolved in small volumes of methylethylketone (MEK) to ensure thorough, 
homogenous mixing. The viscous, homogenous mixture was then placed onto a glass 
substrate or silicon master, underneath a crystallization dish containing open MEK vials 
for slow evaporation overnight. The films are then placed in the vacuum oven overnight 
for full removal of solvent. In the case of photoinitiators, the films were purged using 
nitrogen for ten minutes. The films were then cured using 365 nm wavelength light in a 
UV oven for typically ten minutes under constant nitrogen flow. In the case of thermal 
initiators, films were placed in an isothermal oven at different temperatures for various 
time intervals. Temperature and cure times were explored for facile, rapid curing 
procedures. The amount of radical trap added to the copolymer was kept at 5 or 10 wt-%, 
while the initiator concentration was held at 1 wt-%. Three wt-% was briefly investigated 
to ensure the most effective and efficient crosslinking was being achieved but no change 
in mechanical or surface properties was found using this increased initiator concentration. 
Thin films or replica molds of the cured mixtures were fabricated and characterized. Thin 
films were also poured onto silicon masters to study pattern replication and wettability. 
 
2.3.2.1 Initiators: Thermal. Current benchmark VF2-based elastomers are 
typically crosslinked thermally using coagents and thermally degradable peroxides. The 
following thermal initiators were investigated: 2,2-azobis(2-methypropionitrile) (AIBN), 
benzoyl peroxide (BPO) and di(2-ethylhexyl) peroxy dicarbonate (EHPDC). Though 
attempts were made to cure our materials using thermal initiators, challenges to obtain 
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smooth surfaces on the solid elastomers were unable to be overcome. The main 
challenges that prohibited smooth film formation included cure temperatures at 
reasonable half lives above the boiling point of the coreagent and not having access to 
sophisticated molding devices that would result in smooth surfaces. In comparison to the 
photoinitiators, the thermal initiators had a lower success rate in curing the liquid 
precursors. Preliminary studies (without liquid precursors) show that cure mixes 
containing one weight percent initiator (except in the case of BPO), fails to initiate the 
crosslinking of the radical trap at a sufficient enough rate, so the end product remained 
uncured or only partially cured. The preliminary studies also confirmed that the 
crosslinker 1,4-cyclohexane dimethanol divinyl ether (CDE), is completely unsuitable for 
our system due to extremely low reactivity. 
When using EHDPDC, a one hour reaction time was insufficient in producing 
fully cured, non-tacky and flexible elastomers, even though the preliminary studies 
without the liquid precursor in the cure mix showed some promise. A possible reason for 
the failure to cure is because peroxides are commonly known to undergo ß-scission at 
higher temperatures (more than 70 ºC in the case of EHPDC), and decompose into the 
methyl radical and a carboxylic acid. This is an uncontrollable side reaction, that can 
reduce the efficiency of the propagation step and hence the crosslinking reaction. 
Obtaining fully cured elastomers with smooth surfaces were unsuccessful when a thermal 
initiator. Investigations continued in efforts to find coreagents that would result in fully 
cured elastomers with desirable properties.  
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  2.3.2.2 Initiators: Photochemical. Among the photoinitiators, 2,2-dimethoxy-2-
phenylacetophenone (DMPA), hydroxycyclohexyl phenyl ketone (HCPK), 2-hydroxy-2-
methyl propiophenone (HMP), and diethoxyacetophenone (DEAP) were investigated. 
Reactions with DMPA resulted in the most efficient and effective crosslinking, because 
in the free radical bromine abstraction mechanism the benzoyl radical produces a very 
short triplet state lifetime (0.25 ns) and a dissociation quantum yield of 0.95, the highest 
of all type I photoinitiators.  Experiments on four different types of photoinitiators 
demonstrated that 2,2-dimethoxy-2-phenylacetophenone (DMPA) was the superior 
initiator for producing fluoroelastomers of excellent chemical and thermal stabilities. 
Lalevee et al. have conducted a study into the reactivities of cleavable photoinitiators in 
photo-polymerization reactions.40 In the paper, they reported that the benzoyl radical has 
an initiation rate constant (ki) on the order of 104 M-1s-1, compared to the ki of aliphatic 
and aromatic ketyl radicals (rate is on the order of 107 M-1s-1 in methyl methacrylate and 
methyl acrylate). Although benzoyl radicals react with monomers at a lower rate 
constant, they will add to the unsaturation of vinyl monomers. The deactivation routes 
include reaction with oxygen and termination with another radical. This has two 
important consequences in determining the cure efficiency: termination side reactions 
with constituents of the polymerization mixture are prevented, and monomer quenching 
is not a competitive reaction to the α-cleaving process. Also DMPA is a photoinitiator 
that is designed especially for free radical vinyl polymerizations, and is the most 
prominent member of its class. Diethoxyacetophenone (DEAP) does have the benefit of 
initiating crosslinking to produce highly elastic membranes however, but sol-gel analysis 
proves that these are not necessarily the best crosslinked elastomers. Lower sol fractions 
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were obtained when DMPA was used over DEAP as a photoinitiator and thus produced 
better crosslinked networks. Table 2-7 summarizes elastomer stabilities when using 
DMPS as a photoinitiator. Elastomers cured with 2-hydroxy-2-methyl propiophenone 
(HMP) left in THF for 20 hours, produced one of the highest percentage weight loss of 
gel, at 35.6 %. This was using a cure mix of p(73:27 VF2/EVEBr) with 25:5 wt-% 
TAIC/HMP.  
Finally hydroxycyclohexyl phenyl ketone (HCPK) gave the poorest performance 
as a photoinitiator in efforts to initiate crosslinking of the functional fluorooligomers. 
Even using high amounts (up to 7 wt-%) of HCPK failed to initiate the crosslinking 
process. Greater than three wt-% of photoinitiator in the cure mixture was needed to 
produce successfully cured membranes. There is of course room for improvement, for 
example increasing the cure time and reducing its temperature according to the half-life 
of a thermal initiator. However the aim of the project was to alleviate reaction times, and 
improve processability and reactivities of the reagents. There are some difficulties with 
the handling of the extremely reactive, exothermic thermal initiators, and alternative 
methods of transferring the cure mix onto the substrate without the use of external stimuli 
such as a heat gun, need to be employed. There are also purification, solubility, and 
toxicity issues with the initiators tested. So because thermal initiators have reactivity 
issues and do not perform to the same consistency as photoinitiators that undergo 
controllable α-scission, there would be no further advantages in optimizing thermal 
initiator conditions.  
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Table 2-7.  Chemical stability summary of cured elastomers. 
p(VF2/EVEBr/TFE) 
mole ratioa TAIC (wt%) DMPA (wt%) 
Performance in 
THF 
(21/34/45) 
 10 5 
Stable to solvent 
remains intact 
(24/40/36) 
 5 5 
Unstable to solvent 
swells and fractures
(24/40/36) 
 10 5 
Stable to solvent 
remains intact 
(52/73/10) 
 10 5 
Stable to solvent 
remains intact 
(60/40/0) 
 10 5 
Stable to solvent  
flexible, swollen 
(62/38/0) 
 
25 5 Unstable to solvent swells and fractures
10 5 
Stable to solvent 
remains flexible 
but slightly 
fractured 
(66/34/0) 
 10 5 
Stable to solvent 
remains intact 
(71/29/0) 
 10 5 
Stable to solvent 
flexible, swollen 
remains intact 
(80/20/0) 10 5 Stable to solvent  flexible, swollen 
a: obtained using 19F-NMR; 
 
 
2.3.2.3 Radical Trap Crosslinkers. Radical traps are compounds with a high 
affinity for free radical species and in this context contain vinyl groups and functions as a 
crosslinker. The choice and concentration of a radical trap to crosslink the functional, 
liquid oligomers play an important role in the extent of crosslinking. Different 
compositions were investigated to discover optimal cure conditions. Allylic and vinyl 
radical traps were studied including triallyl isocyanurate (TAIC), 1,4-cyclohexane 
dimethanol divinyl ether (CDE), and di(acryloyl) piperazine (DAP). Triallyl isocyanurate 
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(TAIC) proved to deliver the best results in curing these flourooligomers, as it is the 
leading radical trap for conventional fluoroelastomers cured via a radical mechanism. The 
divinyl ethers would have complemented the overall polymer structure, however even 
with initiator feeds as high as seven weight percent of thermal or photochemical 
initiators, successful curing was unattainable. Vinyl ethers do not homopolymerize in the 
presence of radical initiators due to their electron rich double bonds and their reactivity 
can be challenging even to copolymerize with certain monomers. Divinyl ethers are more 
suitable for use in cationic systems, where the monomer being crosslinked contains at 
least two reactive groups (e.g. divinyl ethers and bismaleimides), unlike the 
fluoropolymers in this study that contain only one reactive site on the cure site monomer. 
Di(acryloyl) piperazine proved problematic due to onset of crystallization upon solvent 
removal. 
With increasing concentration of the radical trap in the cure mix, the mechanical 
properties of the cured membrane became increasingly brittle and less flexible.  If 
homogenous mixing is not ensured and more functional groups are present relative to 
CSM sites, increasing brittleness is expected as the radical trap would homopolymerize 
significantly decreasing the overall average molecular weight between crosslinks. With 
decreased molecular weight between crosslinks, chain mobility decreases and overall 
flexibility is compromised in exchange for a rigid material. The elastomer also became 
opaque as feed ratios of TAIC surpassed 25 weight percent. It should be noted that 
removal of the inhibitor in the radical trap was pertinent. A few experiments adding the 
radical trap inhibited and deinhibited at the same concentration clearly showed that 
successful cure states were obtained when the radical trap was deinhibited. 
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2.3.2.4 Mechanism. Similar to reaction Scheme 1-3 in Chapter 1, the synthesized 
oligomers undergo bromine abstraction and are incorporated into a crosslinked network 
in the presence of a radical trap. The main difference is the origin of the radical source. In 
Scheme 1-3, the radical source originates from the thermal decomposition of a peroxide. 
Here, the less conventional radical source results from the UV decomposition of a 
photoinitiator. The generation of polymeric radicals is attained in the abstraction of 
bromine on the end of the cure site chain, which in turn adds onto the electron rich allyic 
bonds of the radical trap. Eventually a dense 3-dimensional network of fluoropolymers 
covalently linked together with the radical trap, is formed. Figures 2-8 through 2-11 
illustrate optical images of cured elastomers. 
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Scheme 2-4. Crosslinking functional oligomers in the presence of DMPA and TAIC. 
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Figure 2-8. Optical image of p(88:12 VF2/EVEBr) cured using 25:1 wt-% of 
TAIC/DMPA. 
 
  
Figure 2-9. Optical image of p(55:45 VF2/EVEBr) cured using 25:5 wt-% of 
TAIC/DEAP. 
 
           
Figure 2-10. Optical Image of p(88:12 VF2/EVEBr) Cured using 25:5 wt-% of 
TAIC/DEAP. 
 
 
 
Figure 2-11. Optical image of p(63:37 VF2/EVEBr) cured using 25:5 wt-% of 
TAIC/DEAP. 
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2.3.3 Characterization. 
 2.3.3.1 Thermal Analysis. Thermal stability is typically noted by the temperature 
at which five weight percent of a sample is lost using Thermal Gravimetric Analysis 
(TGA). Thermal stability analysis was conducted on cured elastomers of different 
compositions and compared to the original liquid prepolymer before crosslinking. 
Differential Scanning Calorimetry (DSC) was used to analyze thermal properties, 
including glass transition temperatures. The cured elastomers were characterized and 
compared to the respective functional prepolymer. 
 
 2.3.3.1.1 Thermogravimetric Analysis (TGA). Samples of cured elastomers 
were analyzed using TGA under a constant heating rate of 10 °C. The sample mass was 
monitored with respect to temperature. Thermal stability was measured as the 
temperature at which five weight percent of sample was lost. Upon crosslinking the liquid 
precursors, the materials became increasingly thermally stable, as expected. Table 2-7 
summarizes the thermal properties of the cured elastomers. In going from an uncured 
oligomer to a cured elastomer, there is a significant increase in the temperature at which 
the material undergoes a five percent weight loss (mean temperature is 576.6oC). This 
thermal stability is a result of the established network matrix, the lack of labile functional 
groups, and the triazine composition of the radical trap. 
 
2.3.3.1.2 Differential Scanning Calorimetry (DSC) Analysis. An increase in the 
glass transition temperatures upon crosslinking of the fluoropolymer oligomers is evident 
as illustrated in Table 2-8 and Figures 2-12 and 2-13. The explanation for this behavior 
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again lies in the structural differences in the polymer chains between the cured and 
uncured states. As the crosslinking of the fluoropolymers occurs, chain mobility 
decreases resulting to an increase in glass transition temperature. The glass transition 
temperature remains relatively low however, below room temperature, ensuring 
elastomer properties. 
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Figure 2-12. DSC thermograms illustrating glass transition temperatures of cured and 
uncured elastomers p(55:45 VF2/EVEBr); a. uncured; b. cured with 25:5 wt-% of 
TAIC/DMPA.  
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Figure 2-13. DSC thermogram illustrating glass transition temperatures of cured and 
uncured p(88:12 VF2/EVEBr) (88/12); a. uncured; b. cured with 25:5 wt-% of 
TAIC/DMPA.  
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Table 2-8. Thermal properties of cured and uncured fluoroelastomers. 
p(VF2/EVEBr/TFE) 
mole ratioa 
(TAIC/PI) 
(wt %) 
5 % weight 
loss (oC)b 
Tg (uncured) 
(oC)c 
Tg (cured) 
(oC)c 
(21/34/45) (10/5) 562 -28 -19 
(24/40/36) (10/5) 583 -30 -21 (5/5) 582 -21 
(52/73/10) (10/5) 583 -27 -20 
(57/43/0) 
(25/5) 595 
-59 
-13 
(25/5) 556 -12 
(10/5) 587 -13 
(60/40/0) (10/5) 575 -31 -16 
(62/38/0) 
(25/5) 563 
-54 
-19 
(25/5) 591 -17 
(10/5) 558 -12 
(63/37/0) (25/5) 583 -37 -19 (25/5) 566 -19 
(66/34/0) (10/5) 576 -25 -15 
(71/29/0) (10/5) 576 -25 -17 
(73/27/0) (25/5) 563 -38 -19 
(80/20/0) (10/5) 585 -30 -22 
(88/12/0) (25/5) 595 -37 -23 
a: obtained using 19F NMR; b: obtained by TGA; c: obtained by DSC 
 
 2.3.3.2 Swelling, Stability, and Sol-Gel Analysis. Swelling experiments of cured 
elastomers were initially conducted in methylene chloride solvent And then for a more 
thorough analysis the chemical stability of cured elastomers they were investigated in 
tetrahydrofuran (THF) as well. Experimental results are summarized in Table 2-8. 
Swelling experiments offer useful information regarding the efficiency of the 
crosslinking reaction. A covalently crosslinked elastomer by definition will not dissolve 
in any solvent. Polymer chains may however be extracted from the network if they were 
not incorporated into the cured matrix and are not extensively entangled throughout the 
network. Swelling data illustrates the material’s propensity to a particular solvent and 
typically determined by dimensional changes. The dimensions of a regularly shaped piece 
of elastomer are first measured along with its mass and then the material is soaked in a 
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solvent for a given measure of time. After the given amount of time, the material is 
removed from the solvent, blotted dry and the dimensions and mass are determined again. 
The difference in mass and dimensions before and after swelling are used to calculate the 
swelling.  
Dimensional change upon solvent exposure was challenging to record as the films 
were increasingly fragile in the swollen state. Elastomers cured from higher molecular 
weight oligomers proved to be more chemically stable and were less brittle than the 
materials resulting from lower molecular weight precursors. With increasing amount of 
TFE incorporated into the prepolymer, the chemical resistance increased as well. 
Elastomers exposed to acid or base remained chemically inert as evident by no or little 
dimensional change and the lack of dissolution.  
The chemical stability of the fluorinated elastomers using swelling experiments in 
THF and sol-fraction analysis using Infrared (IR) Spectroscopy and Gel Permeation 
Chromatography (GPC) was investigated. Cured elastomer samples soaked in THF for 
four hours and again for at least 20 hours. After samples soaked in THF for four hours, 
elastomer samples were extracted and the THF solution was analyzed using GPC. The 
procedure was repeated for 20 hours of soak times of the fluorinated elastomer in THF. 
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 2.3.3.2.1 Infrared Spectroscopy. The IR spectra of the cured elastomers (gel 
portion) differed from the spectra of the respective sol-fractions. Most notably, the 
difference was found in the presence of the crosslink functionality groups, the methylene 
and triazide groups, in the gel portion. Figure 2-7 illustrates a typical IR spectrum of a 
gelled elastomers and the respective sol-fraction after 20 hours. Two significant stretches 
associated with the elastomer gel are present between 3440 and 3370 cm-1 and between 
3060 and 2850 cm-1. The first series of peaks in the region of 3440–3370 cm-1 are from 
either the amide groups (on the radical trap) or from carboxylic acid groups, potentially 
generated by β-scission of the aromatic ketyl radical (Scheme 2-3). The other series of 
stretches in the 2960 cm-1 region are from the saturated C−H groups on the link between 
the fluoropolymer and radical trap (Figure 2-6), giving evidence that the materials have 
been successfully crosslinked. The lack of unsaturated stretches, typically appearing at 
3095 to 3010 cm-1 for the =C−H stretch or at 1660 to 1600 cm-1 for the −C=C− bend, 
gives evidence that unreacted radical trap is not present.  
A typical IR spectrum of the sol-fractions is illustrated in Figure 2-11. As 
expected, the presence of peaks at 1173 and 906 cm-1 confirm the presence of −CF2− and 
C−F groups. The absence of a bromine peak, which should appear in the region 690 – 
515 cm-1, suggests that the sol-fractions contained negligible amounts of CSM 
incorporated into the fluoropolymer chain.  It is possible that CSMs incorporated into the 
polymer chain underwent substitution reactions with hydrogen atoms perhaps, without 
being incorporated into a crosslink.  
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Figure 2-14. Infrared spectrum of sol-fraction from copolymer p(55:45 VF2/EVEBr) 
cured with 25:5 wt % TAIC/DMPA. 
 
2.3.3.2.2. Gel Permeation Chromatography. Molecular weight analysis of the 
sol-fractions was conducted using Gel Permeation Chromatography (GPC). The results 
are summarized in Tables 2-9 and 2-10 for co- and terpolymers, respectively. The 
difference in average molecular weights between the parent oligomer (Mn parent) and the 
sol-fractions of the elastomers becomes relatively less significant as the Mn of the parent 
liquid precursor increases. For example, the oligomer, p(73:27 VF2/EVEBr) is composed 
of a number average molecular weight of 6.2 kg/mol and the Mn of the respective sol-
fraction consisted of 4.4 Kg/mol. In examples concerning terpolymers, oligomers 
composed of p(21:34:45 VF2/EVEBr/TFE) had a number average molecular weight of 41 
kg/mol. This is in drastic comparison to the sol-fraction containing a number average 
molecular weight of 5.3 kg/mol. Curing reactions were thus more efficient and effective 
with terpolymer compositions in producing a more stable network. However, less 
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terpolymer samples were utilized, as indicated in Table 2-10, as homogenous mixing of 
cure components was challenging in some cases and therefore the fabrication of 
elastomers were unattainable. 
A few elastomer samples were exposed to solvent for three hours. The sol-
fraction was collected and the same sample was exposed to more solvent for at least a 
total of 20 hours. Results obtained from GPC indicate that the molecular weight of the 
sol-fraction obtained after 20 hours is slightly larger than that obtained from the sol-
fraction after three hours. Both samples contain polymer chains of lower average 
molecular weight compared to the prepolymer before crosslinking. The trend, illustrated 
in Figure 2-15, can be explained by the following: during the three hour solvent soak, 
polymer chains that are not covalently incorporated into the matrix and are soluble in the 
solvent will migrate from the matrix. Smaller chains (lower molecular weight) have 
greater mobility and are less entangled in the network. These lower molecular weight 
chains diffuse out of the matrix first. Subsequent to the diffusion of the low molecular 
weight chains, the elastomer has void volumes where the chains used to reside. The void 
volumes allow for larger molecular weight chains to gain greater mobility, thus 
detangling themselves from the network and diffusing in the solvent continuous phase. 
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Figure 2-15. GPC traces of a. p(55:45 VF2/EVEBr) and sol-fractions of elastomer cured 
with  25:5 wt % of TAIC/DMPA after b. 24 hours and c. after three hours in THF. 
 
 
 
 
a. Mn= 11.6 K 
b. Mn= 8.1 K 
c. Mn= 5.8 K 
a. 
b. 
c. 
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Table 2-9. Sol-gel analysis summary of p(VF2/EVEBr) copolymers using GPC. 
p(VF2/EVEBr) 
mol%a 
 
(TAIC/PI) 
weight% 
 
Mn 
(parent) 
[kg/mol]
b 
 
Mn (sol-
fraction) 
[kg/mol]b 
 
Mw (sol-
fraction) 
[kg/mol]b 
 
 
PDIb 
 
% sol 
fraction 
(20hrs 
in 
THF)c 
 
55:45 
(10/5) 
11.6 
8.0 12.2 1.52 19.9 
(25/5) 2.9 7.4 2.57 7.59 
(25/5) 2.9 6.5 2.28 5.3 
(25/5) 5.5 12.4 2.27 21.6 
57:43 (10/5) 9 2.9 7.3 2.5 9.1 (25/5) 4.3 6.4 1.5 18 
(25/5) 3.4 6.2 1.8 14.7 
60:40 (10/5) 14 3.5 8.9 2.5 12 
62:38 
(10/5) 
13 
3.3 6.9 2.1 6 
(25/5) 5.5 9.2 1.7 12 
(25/5) 3.2 6.6 2.1 11.4 
63:37 (25/5) 7.4 3.6 6.2 1.71 18.7 4.5 7.8 1.75 22.9 
73:27 (10/5) 6.2 4.4 7.4 1.67 22.98 (10/5) 3.4 8.9 2.65 41.6 
(25/5) 3.3 5.6 1.68 17.4 
80:20 (10/5) 15 3.6 10.4 2.9 10 
88:12 
(10/5) 
7.3 
3.9 6.8 1.77 15.9 
(25/1) 5.7 9.7 1.7 26.9 
(25/5) 2.7 5.6 2 8.9 
(25/5) 4.2 7.8 1.84 34.3 
(50/1) 4.9 9.4 1.9 19.8 
(50/5) 4.5 8.4 1.85 32.7 
a: obtained by 19F-NMR; b: obtained by GPC; c: obtained gravimetrically.  
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Table 2-10. Sol-fraction analysis summary of cured p(VF2/EVEBr/TFE) terpolymers. 
a: obtained by 19F-NMR; b: obtained by GPC; c: obtained gravimetrically. 
 
 2.3.3.2.3. Nuclear Magnetic Resonance Analysis. Sol fractions were analyzed 
using 19F-NMR in order to obtain structural information of the sol-fraction and efficiency 
of the crosslinking method. Figure 2-16 illustrates a fluorine spectrum of the sol-fraction 
obtained from p(24:40:36 VF2/EVEBr/TFE) cured with ten weight percent of TAIC and 
five weight percent of DMPA for 24 hours. This terpolymer under the noted conditions 
resulted in the most stable elastomer. After the 24 hour soak in THF only 1.7 weight 
percent was lost in the sol-fraction, the least of any other fabricated elastomer. Figure 2-9 
also illustrates that no fluorinated methylene group adjacent to a bromine atom is present, 
expected at -71 and -72.5.37 This indicated that CSMs were not present in the sol-fraction 
and that the crosslinking was very efficient, further illustrated by the low weight percent 
loss of the sol-fraction.  
(VF2/EVEBr/TFE) 
mole ratioa 
(TAIC/DMPA) 
weight % 
Mn (parent) 
[kg/mol]b 
Mn (sol-
fraction) 
[kg/mol]b 
% weight loss 
(elastomer in 
THF for 20 
hrs)c 
(24/40/36) (10/5) 21 3.1 1.7 
(52/73/10) (10/5) 25 3.3 9.1 
(21/34/45) (10/5) 41 5.3 23.2 
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Figure 2-16. 19F-NMR spectrum of sol-fraction obtained from cured p(24:40:36 
VF2/EVEBr/TFE) elastomer with 10 wt-%  TAIC and 5 wt-% DMPA.  
 
 2.3.3.3 Surface Energies. Static contact angle were measured using distilled 
water and diiodomethane on thin films of cured elastomer. Measurements were repeated 
a minimum of three times on separate locations of the film, and average contact angles 
were calculated. The surface energies of the cured polymer films were evaluated using 
the Owens-Wendt-Fowkes equation. According to this approach, the surface energy of a 
solid (γs) can be resolved into dispersion and polar components (dγs and pγs, respectively) 
(Equation 2-1). 
 
  s
d
l
d
l
p
s
p
l
d
l γγ
γγγ
γθ +•=•+ )5.01(5.0                                        (2-1) 
 
where θ  is the contact angle. If contact angles of two liquids, for which the surface 
tension (γl) and the dispersion and polar components (dγl and pγl, respectively) are known, 
one can calculate the surface free energy of the solid via equation 2-1. The surface 
tension and respective components for water and diiodomethane are summarized in Table 
2-11 and were employed for the calculations of the surface free energy of our cured 
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polymer samples.  The samples were prepared via solvent casting films of the cure 
mixture onto a glass slide and placing in a solvent saturated environment overnight for 
slow evaporation. The samples were then dried in the vacuum oven overnight or until a 
constant weight had been reached. The samples were then placed in the UV oven 
chamber with nitrogen purge for ten minutes, followed by irradiation for five to ten 
minutes under constant nitrogen purge. Static contact angles were measured using water 
and diiodomethane. Average values are summarized in Table 2-12. The calculated 
surface free energies and the respective components thereof are summarized in Table 2-
13. 
 
Table 2-11. Surface tension properties for test liquids for static contact angle 
measurements. 
 
Test Liquid γl [mN/m] dγl [mN/m] pγl [mN/m] 
Distilled Water 73 22 51 
Diiodomethane 51 50 1 
 
Table 2-12. Static contact angle measurements. 
P(VF2/TFE/EVEBr) Avg H2O contact θ Avg CI2H2 contact θ 
34:48:18 96 39 
64:27:9 91 53 
66:0:34 83 59 
71:0:29 74 58 
73:20:7 83 56 
76:13:11 102 60 
76:7:17 93 46 
82:8:10 97 57 
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Table 2-13.  Owens-Wendt-Fowkes calculations. 
P(VF2/TFE/EVEBr) γs [mN/m] pγs [mN/m] dγs [mN/m] 
34:48:18 40 0 40 
64:27:9 33 2 31 
66:0:34 31 6 26 
71:0:29 36 10 25 
73:20:7 33 5 28 
76:13:11 29 0 29 
76:7:17 36 1 35 
82:8:10 31 1 30 
  
  
The average water contact angles ranged between 83 and 102 degrees. For 
diiodomethane, resulting average contact angles spanned between 39 and 60 degrees. It is 
evident from Table 2-13, that the major contribution to the solid surface energy arises 
from the polar components. In some cases the dispersion components barely contribute to 
the surface energy term. Calculated surface energies for synthesized terpolymers ranged 
from 29 to 40 mN/m. Though these values may be higher than typically expected for the 
fluoroelastomer, it is possible that the hydrocarbon content of the radical trap and 
methylene groups of VF2 affect the contact angles measured. The contact angles were 
measured at the air/polymer interface. Molecular chain rearrangement at the air/polymer 
interface could bring hydrocarbon-rich groups to the surface, thus further impacting 
contact angle measurements. 
 
2.3.3.4 Modulus Measurements. Solvent cast cure mixtures were prepared using a 
deep mold (ca width = 1 cm; length = 3 cm) using a PTFE gasket. The filled mold was 
placed in a solvent-saturated chamber overnight for slow solvent evaporation. The mold 
was then placed in a vacuum oven overnight or until a constant mass was reached, 
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indicative of complete removal of any residual solvent. The mold was then placed in a 
UV oven and purged with nitrogen for five to ten minutes. Finally, the sample was 
irradiated (365 nm wavelength) for typically ten minutes under constant nitrogen purge. 
The cured sample was then cut out of the mold and used for mechanical property 
measurements using an Instron. The results are summarized in Table 2-14. Figures 2-17 
and 2-18 illustrate stress versus strain curves of different p(VF2/EVEBr/TFE) terpolymers 
cured with 5:10 wt-% of DMPA/TAIC. Having a modulus of 3.5 MPa (p(34:18:48 
VF2/EVEBr/TFE), the material tested in Figure 2-17 could be elongated to a greater 
extent compared to the terpolymer analyzed in Figure 2-18. The material analyzed in 
Figure 2-17 was stretched seven times its length, while the terpolymer analyzed in Figure 
2-18 was stretch just over twice its length before the sample broke. The latter material, 
however, had a higher modulus of 9.9 MPa (p(72:7:20 VF2/EVEBr/TFE). The Young’s 
modulus was taken from the first 5 % of the slope of the stress versus strain plot 
generated by the instrument. The initial indication of increasing modulus with increasing 
TFE content of the precursor proved to differ with some of the samples. Molecular 
weight seemed to have a great influence on modulus, a clear trend could not be found, 
however. The amount of radical trap added to the cure mixture was usually 5 wt-% in 
order to maintain a relative comparison to benchmark fluoroelastomers. It should be 
noted that the best results typically included greater than 5 wt-% of radical trap being 
added to the cure mixture. This may be as a result of the low molecular weight 
prepolymers relative to those used in commercial fluoropolymers, more CSM may need 
to be incorporated into the polymer backbone and more radical trap added to the cure 
mixture for complete chemical crosslinking and desirable mechanical properties. Table 2-
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15 summarizes modulus values of common elastomer materials. Modulus values of 
fabricated elastomers from synthesized fluorinate p(VF2/EVEBr/TFE) terpolymers fall 
within working ranges of commercially available elastomers. These results look 
promising and could have their place in soft elastomer applications. 
 
Table 2-14. Mechanical properties of p(VF2/EVEBr/TFE) copolymers. 
VF2 
mol%a 
EVEBr 
mol%a 
TFE 
mol%a 
Mn 
[kg/mol]b 
Mw  
[kg/mol]b Tg [°C]
c Modulus 
[MPa]d 
34 18 48 33 69 -23 3.5 
64 9 27 83 145 -13 11.4 
66 34 0 15 53 -30 3.2 
71 29 0 31 112 -25 1.4 
73 7 20 78 137 -19 9.9 
76 17 7 74 129 -21 8.4 
76 11 13 50 118 -9 4.3 
82 10 8 63 120 -18 12.8 
a: obtained by 19F-NMR; b: obtained by GPC; c: obtained by DSC; d: obtained by Instron. 
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Figure 2-17. Instron testing of cured p(34:18:48 VF2/EVEBr/TFE) elastomer with 10 wt-
% TAIC and 5 wt-%DMPA.  
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Figure 2-18. Instron testing of cured p(73:7:20 VF2/EVEBr/TFE) elastomer with 10 wt-
% TAIC and 5 wt-%DMPA. 
 
Table 2-15. Modulus values of fluorinated materials. 
Material Modulus [MPa] 
Perfluoropolyether (4K) 7.0 
Perfluoropolyether (1K) 89.0 
Polydimethylsiloxane (Sylgard 184) 0.8 
Perfluorinated elastomers 6.0 – 13.0 
Fluorinated elastomers 2.0 – 15.0 
TFE/PP elastomers 2.5 – 3.5 
Fluorinated silicones 1.0 – 6.0 
P(VF2/EVEBr/TFE) terpolymers 1.0 – 13.0 
 
2.3.4 Pattern Replication. Pattern replication was accomplished by pouring the 
liquid cure mixture onto an etched silicon master template and photochemically 
crosslinking the material as described previously. The cured mold was then carefully 
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released from the silicon master resulting in a soft replica. These highly fluorinated VF2 
copolymer cure mixtures were found to completely wet the template surface, creating an 
embossed film of a true and accurate replication of the surface. Silicon masters are 
extremely expensive and whether they are used for imprint lithographic applications or 
device fabrication, utilization of a soft replicate affords a cost effective, reusable, robust 
alternative. Figure 2-9 illustrates SEM micrographs of the silicon master template (A) 
and three fluorinated elastomer replicas (B, C, D). 
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Figure 2-19. SEM micrographs of a silicon master template and replicas made from 
p(VF2/EVEBr) cured with TAIC/DMPA; (A) silicon master template; (B) p(71:29 
VF2/EVEBr) with 10:5; (C) p(48:52 VF2/EVEBr) with 5:5; (D) p(71:29 VF2/EVEBr) 
with 10:10. 
 
 
 
 
 
 
 
(A) (B) 
(D) (D) 
100 µm 100 µm 
50 µm 50 µm 
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Figure 2-20. SEM images of (A) silicone master template; and (B) p(55:45 VF2/EVEBr) 
cured with 25:5 wt-% of TAIC/ DMPA. 
 
2.4 Conclusions: Elastomer Curing. In summary, a novel synthetic approach to the 
fabrication of fluorinated elastomers that is cost effective, environmentally friendly, and 
decreases manufacturing steps was presented. Fluorinated elastomers are commonly 
prepared via free radical emulsion polymerization, which result in aqueous waste and 
energy intensive drying steps. Using scCO2 as a continuous phase for the polymerization 
of fluorinated monomers, the process avoids harmful aqueous waste and is a dry, 
environmentally friendly process. The dry nature of CO2 enables reactive functional 
monomers to be used that one cannot use in aqueous based processes. In some cases the 
cure chemistry could be carried out as a solvent-less process. Easily processable materials 
that could be cured into elastomeric solids were achieved by synthesizing functional, low 
molecular weight oligomers with high fluorine content. Minimal solvent was used in 
some cases to facilitate homogenous mixing of curing components. A systematic study 
varying initiator, monomer feed ratios, percent solids, initiator concentration and pressure 
was conducted for the polymerization of new fluorinated oligomers for elastomer 
applications. Additionally, investigations of different initiators and co-reagents for the 
(A) (B) 
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cure chemistry and the effect on mechanical properties and surface free energy were 
studied. New fluoroelastomers have been prepared from a liquid or semi-solid precursor 
synthesized in supercritical carbon dioxide. These new fluorooligomer precursors were 
then cured into elastomers via a photochemically crosslinking process. Traditional 
reactions to fabricate fluorinated elastomers involve several co-regents for optimum 
crosslinking and to react with unwanted byproducts. A facile process using minimal 
reagents necessary to convert liquid precursors into new, solid fluoroelastomers has been 
demonstrated. Additionally, our synthesis decreases manufacturing costs by avoiding 
energy intensive drying steps that aqueous processes incur. A promising new route for the 
fabrication of fluorinated elastomers has been illustrated. By varying composition and 
cure chemistry one is able to tune the mechanical and surface properties to realize unique 
applications. The liquid cure mixtures were found to easily wet etched silicon surfaces for 
pattern replication. Upon curing the mixture an exact replica of the surface is produced, 
enabling increased utility for specific application including patterned proton exchange 
membranes for fuel cells, soft, solvent-resistant microfluidic devices, and enabling novel 
drug delivery platforms with the fabrication and replication of micron- and nanometer 
sized objects. 
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3.0 Introduction. 
3.1 Liquid Perfluoropolyether Precursors and Their Utility. Perfluoropolyethers 
(PFPEs) are a class of polymers which exhibit an impressive range of properties for 
applications in extreme environments.  Exceptionally high chemical and thermal 
stabilities derived from the strong C-F and C-O bonds in the polymer backbone. As high-
performance lubricants for aerospace and industrial applications, pump and heat transfer 
fluids, as well as additives for surface modification, PFPE materials possess physical and 
chemical properties over a wide range in temperatures.1-8  Similar to functional oligomers 
discussed in Chapter 2, PFPEs are liquid at room temperature. Their aliphatic structure 
and ether linkages result in a totally amorphous morphology. High thermal stability, 
excellent chemical inertness, and low surface tension summarize their intriguing 
properties. Perfluoropolyethers are typically synthesized through anionic ring opening 
polymerizations of hexafluoro propylene oxide. Less conventional synthetic routes 
include the photooxidation of fluoroolefins as with tetrafluoroethylene (TFE) and 
hexafluoropropylene (HFP), or through Lewis acid-catalyzed ring opening 
polymerization of 2,2,3,3-tetrafluorooxetane followed by direct fluorination under UV 
light.4 Lagow and coworkers also achieved the PFPE synthesis by direct fluorination of 
hydrogenated polyethers.9 Bunyard and coworkers described the photooxidation of HFP 
in carbon dioxide10 as an environmentally friendly alternative to organic and fluorinated 
solvent systems. They exploit the benefits of utilizing an environmentally friendly and 
tunable continuous phase. Functionalization of PFPE can be accomplished using a 
number of different chemistries.11, 12 A common PFPE, ZDOL, contains alcohol end 
groups that can postfunctionalized with 2-isocyanatoethylmethacrylate in the presence of 
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catalyst to afford a methacrylate-terminated PFPE. With a functionality of four, this 
liquid material can be crosslinking into a solid elastomer network with the addition of an 
initiator and stimulus (heat or UV irradiation, depending on the initiator). Cured PFPE 
materials may not result in the most chemically or mechanically robust properties 
attributed to more traditional flouroelastomers, they do however bring unique attributes 
that advancing industries in nano- and biotechnology are exploiting. 
 
3.2 Novel PFPE Applications: in Microfluidic Device Fabrication and Soft 
Lithographic Applications in Pattern and Particle Replication, PRINT Technology. 
Recent progress has established PFPE-like materials as leading benchmark materials for 
solvent resistant, soft microfluidic devices (Figure 3-1). Such lab-on-a-chip devices 
enable combinatorial chemistry and screening reactions, separations, in-situ analyses and 
rapid synthesis of radio labeled 19F contrast agents for PET imaging7, 8 using nanoliters of 
reagents. Rapid drug screening in microfludics, novel routes to DNA and peptide synthesis, and a 
wide scope of new combinatorial organic reactions, previously unavailable in PDMS microfluidic 
devices13-17 are realized in a PFPE-based microfluidic device and maintains the cost effectiveness 
compared to hard devices made from glass or silicon. Devices fabricated from photocurable 
PFPEs7, 8 were first reported by Rolland and coworkers. The devices are composed of 
replicated, patterned layers obtained by using master templates and imprint lithography 
(Figure 3-2). The uncanny wetting properties of uncured PFPE realizes unsurpassed 
precision in replicating patterns on size scales on the order of nanometers.6-8, 18 
Whitesides and coworkers have pioneered efforts in soft and imprint lithography using 
poly(dimethylsiloxane) (PDMS) based materials.13-17, 19-22 Rolland and coworkers have 
shown that even the benchmark PDMS materials could not replicate intricate patterns 
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with the utmost fidelity.23 Poly(dimethyl siloxane) based liquids are also incapable of 
wetting features as clearly as PFPE- type liquids.  
  
 
Figure 3-1. Image of a soft microfluidic device.  
 
 
Figure 3-2. Illustration of pattern replication using traditional imprint lithography. 
 
 
 
As illustrated in Figure 3-2, a PFPE mold comes into contact with a curable liquid on a 
substrate (here a Si wafer). Using in this case UV radiation, the curable liquid is crosslinked into 
a solid network. Subsequent to curing, the PFPE is released, leaving a patterned replica of the 
PFPE mold. PFPE maintains flexibility and conformal contact with a remarkably low surface 
energy which facilitates unprecedented release from substrates. They also have excellent feature 
integrity. Imprint lithography traditionally replicated patterns and features and with a stamping-
like technique leaves the land area between the features containing the stamped material, as 
illustrated in Figure 3-2. Rolland and coworkers exploited the non-wetting and facile release 
UV curable 
liquid 
Mold / cure release
Si Wafer 
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properties by bringing a PFPE mold into contact with another PFPE, flat surface. When a 
monomer solution becomes sandwiched between a mold and a flat surface, the formation of 
discrete features is realized as the excess curable liquid is pushed out. Building on this work, an 
emerging technology developed, referring to Particle Replication In Non-Wetting Templates 
(PRINT).18  
 
3.3 The Microelectronics Industry Meets Personal Health Care.  It is evident that 
research originating from the microelectronics industry is becoming a benchmark for bio- 
and nanotechnology. The precision fabrication technology of the microelectronics 
industry is translating the field of bioengineering and nanotechnology and fundamentally 
altering the landscape of medicine. Methodology and fabrication processes in 
nanoparticle synthesis and templating13, 24-30 are being expanded and utilizing procedures 
typically used to make microchips. It has thus become increasingly apparent that imprint 
and soft lithography are tools that the life sciences are exploiting for pattern replication,6 
templating of biomaterials,16, 28, 30-34 and for synthesizing drug delivery vectors.35-37 Only 
until recently has the fabrication of organic, shape-specific, monodisperse nanoparticles 
for therapeutics and drug delivery vectors been realized through imprint lithography 
using non-wetting templates.35 Rolland et al. reported the first particle fabrication 
strategy demonstrating rigorous control over size, shape, composition, surface decoration, 
and deformability.18 This versatile “top-down” method to fabricate discrete particles 
using traditional lithographic processes opens up new possibilities for fundamental and 
applications driven research, previously unattainable. 
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3.3.1 Fabrication of Discrete, Shape-Specific, Monodisperse Polymer 
Nanoparticles Using PRINT. Bio- and nanotechnology is becoming an ever growing 
and exciting research field with billions of dollars being invested in hopes of developing 
state-of-the-art therapeutics, contrast agents, delivery vectors, devices, coatings, smart 
particles, and other biomedical applications for overall improvement in personalized 
health care. Emerging bio- and nanotechnology are adapting methodology of the 
microelectronic industry to create novel drug delivery platforms opening up unlimited 
opportunities in areas such as disease fighting, improved health sustainability, and 
finding cures. Particle Replication In Non-wetting Templates, PRINT, enables the 
fabrication of discrete, shape-specific, monodisperse drug delivery vectors. PRINT 
exploits the wetting properties of functionalized PFPE to completely wet the surface of 
silica master templates to create an elastomeric mold of the inverse pattern. This mold is 
used to create nano- and microparticles by filling each cavity of the mold and avoiding an 
interconnecting layer, a so called flash layer, to produce discrete, shape-specific particles. 
Compositions already investigated are PEG-based systems, PLGA, poly(pyrrole), 
triacrylate and diacrylate systems and variations thereof. Various fabrication 
methodologies have been established and investigated for ease, speed, and composition 
dependency. Different shapes were studied in cylinders, trapazoids, conical, arrows, and 
bars for initial investigation and since have been broadened to include more biologically 
relevant shapes and sizes. 
 
 3.3.2 Drug Delivery and Nanotechnology Platforms: Shape and Size 
Matter. Bio- and nanotechnology are quickly realizing that size and shape holds vast 
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significance and at times consequence in biological mechanisms and processes6, 37-47 
These nanofabricated tools (e.g., precisely defined particles) hold significant promise to 
provide insight into the fundamentals of cellular and biological processes as they can 
yield essential insights into the design of effective vectors for use in nanomedicine. 
Systems to date have the ability to fabricate either ill-defined particles or systems where 
there is little control to systematically vary the key variables of size, shape, deformability 
and surface chemistry until PRINT. The effect of these variables on biological systems 
has largely been unexplored, mostly due to the fact that no methodology has been 
developed coming even close to the breadth that the PRINT process offers. No other 
fabrication process is as unique as the PRINT technology. 
 
3.3.3 PRINT Micro- and Nanoparticles: Implication in Cancer Research. 
Therapies to treat diseases such as cancer have yet to realize facile, 100 % effective 
treatment regiments that circumvent undesired side effects. Additional challenges that 
anti-cancer therapeutics face is increasing drug tolerances developed by patients, non-
specific cell killing, and general toxicities. On top of that, each individual cancer and 
their stages often require a unique approach to therapy and has unmet needs for effective 
treatment agents or cocktails thereof. The holy grail of a therapeutic drug delivery vehicle 
may comprise many unknown variables, variables that have been undiscovered and 
unexplored due in part to the limited fabrication procedures present to date. There are 
however a few characteristics known to affect outcomes within biological mechanisms 
and processes. Size and shape of a drug carrier have tremendous implications.45, 47 An 
ideal size range (below 500 nm) will allow drug carrier circulate for longest time periods 
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compared to micron sized particles. The careful investigation of a monodisperse (in size 
and shape) carrier has a tremendous impact on particle performance. Monodispersity is a 
key property to enable optimal non-specific targeting and incur the highest efficiency of 
therapeutic index.  
 One aspect of an ideal approach utilizes a drug carrier which is non-toxic, is not 
recognized as foreign to the body and carries the drug to a target area, i.e, a tumor, and 
does not release its cargo before being internalized by the tumor cell. In order to 
accomplish one of those characteristics of a delivery vehicle, free drug has to be 
encapsulated into the delivery vector such as a polymer matrix. This matrix should be 
readily soluble within a cell, but tightly shielding the drug until internalization to 
decrease or eliminate toxicity issues. As such crosslinks of the matrix could be composed 
of labile groups, reactive only under specific conditions such as a reducing environment, 
enabling an activated release. The rest of the matrix, the raw polymer, is ideally soluble 
in aqueous media, such that without the crosslinks the particle would not retain its shape 
and dissolve.  
 Petros and coworkers reported encapsulation of doxorubicin into a degradable 
disulfide matrix.35 Upon internalization of the vector in a cell, doxorubicin is released in 
response to the reducing environment. This study illustrated HeLa cell killing in vitro by 
release of the doxorubicin without the addition of any external reducing agent. Petros and 
coworkers emphasize that the fabrication of nano- and microparticles offer distinct 
advantages over other delivery vectors currently in use such as liposomes, dendrimers, 
viruses, conjugated, and micelles.35 The drug delivery vector discussed by Petros and 
coworkers afford low cargo loading and a more sophisticated matrix is warranted. 
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Figure 3-3. Chemical structure of paclitaxel. 
 
   
3.4 Biomaterials: Leading Forefront of Disease Treatment, Recognition, Sensing, 
and Marking. Synthetic, polymer nanoparticles used as drug delivery vectors have 
overcome some challenges faced with circulation and retention in a human body.48-63 The 
innate behavior to clear unidentifiable, foreign, matrices from the body using different 
clearing mechanisms remains challenging for delivery vectors to overcome. PEGylation 
has introduced nanoparticles to longer circulation times, but even with today’s best 
efforts, no particle recipe has been comparable to circulation times of red blood cell (120 
days). If synthetic particles can never overcome certain barriers of clearance mechanisms 
of the body, what alternatives are left? Proteins circulate in a human for over weeks and 
months. Allowing for long circulation and effective targeting are the next steps in 
nanomedicine and curing cancer.  
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If certain proteins are not recognized as foreign objects and retain the ability for 
long circulation, rapid clearance through uptake in the liver or kidneys or by 
macrophages is circumvented. This is especially needed for anticancer drugs, such as 
doxorubicin or paclitaxel, which often create undesired side effects. The side effects are 
in part as a result to early clearance and non-specific cell uptake. Random cells taking up 
anti-cancer agents are arrested, leading to cell death to otherwise healthy cells. Peripheral 
neuropathy is another such serious side effect of chemotherapy. Peripheral neuropathy 
describes damage to the peripheral nervous system and originates partially from the 
toxicity levels of anti-cancer agents not reaching tumerous tissue, thus being internalized 
by healthy tissue. Some people may experience temporary numbness, tingling, and 
pricking sensations (paresthesia), sensitivity to touch, or muscle weakness. Others may 
suffer more extreme symptoms, including burning pain (especially at night), muscle 
wasting, paralysis, or organ or gland dysfunction. People may become unable to digest 
food easily, maintain safe levels of blood pressure, and sweat normally.  
Part of what is so challenging and eludes current sophisticated treatment 
regimens, is that cancer cells have, for the most part, the makeup of a healthy cell, with 
differences for the most part being exceedingly more rapid growth and cell division and 
have are decorated with significantly more markers and receptors on their cell surface. 
Most cell receptors are identical on cancerous cells compared to healthy tissue. The hope 
is that since cancerous cells have the amplification of receptors, that targeting particle 
platforms would be directed to the cancer cells, and not healthy tissue. This approach 
relies on the partitioning of particles to extent toward cancer cells thus creating a 
exceedingly more effective and efficient therapeutic. Current drug delivery platforms also 
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rely on the EPR effect (Enhanced Permeability and Retention) of cancer cells with their 
leaky vasculature. 
 
3.4.1 Abraxane™: Overcoming Toxicity Hurdles. As eluded to, peripheral 
neuropathy significantly declines a cancer patient’s quality of like. Most anti-cancer 
agents have some levels of peripheral neuropathy associated with treatment, and 
paclitaxel is no exception.64, 65 Paclitaxel (Firgure 3-3), an antineoplastic agent, has a 
unique action by inhibiting microtubule network reorganization which is essential for cell 
division and has proven to be a benchmark drug for the treatment of metastatic breast 
cancer.66, 67 A Solvent-based delivery of paclitaxel was established through a formulation 
called Cremaphor EL, which is Castrol oil and ethanol. The solvent-based delivery 
system of paclitaxel is referred to as Taxol®.68, 69 Due to extremely high toxicity levels, 
the maximum tolerated dose is relatively low and subsequently treatment regiments that 
typically take three hours per dose are prolonged for effectiveness.  Premedication with 
steroids or antihistamines for hypersensitivity reactions caused by these solvents were 
required. Recently, Abraxis Bioscience discovered a formulation containing 10 % by 
weight paclitaxel that was much less toxic and mitigated the use of Cremaphor EL as a 
delivery method. Abraxane™ is a nanoparticle platform composed of paclitaxel bound to 
albumin, the most abundant protein in our circulation.66-74  
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Figure 3-4. Cartoon of the Structure of Albumin. 
 
  3.4.1.1 Background: Abraxane. The albumin-bound paclitaxel was 
approved by the FDA in January of 2005. It comes as a lyophilized power and is 
reconstituted into saline just prior to injection, which is infused over a shortened infusion 
time 30 minutes. Abraxane is formulated using a proprietary coascervation method to 
bind paclitaxel to albumin in a non-covalent mechanism and produces spherical particles 
ranging from 50 to 150 nm in diameter upon reconstitution. It is hypothesized that once 
albumin-bound paclitaxel is in circulation, the particles bind to albumin’s natural 
receptor, gp60, on vascular endothelial cells, just as normal albumin would.75-79 The gp60 
receptor is like many other overproliferated receptors on cancerous cell. The activated 
receptor interacts with cavelein-1 protein leading to caveolae. The caveolae transports its 
cargo then to the tumor interstisum.  For optimal effectiveness, the cytotoxic agent still 
needs to cross the tumor cell membrane. Many tumors have evolved a biological process 
allowing for maximum extraction of albumin-rich nutrients. As such, tumors secrete a 
special protein, SPARC, referring to secreted protein acidic and rich in cysteine, into the 
tumor interstsum. The SPARC acts as a receptor to find and bind to albumin. As a result 
of SPARC’s rich affinity to albumin, it attracts and binds to albumin-bound paclitaxel, 
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concentrating it at the tumor cell surface. The cytotoxic agent is released and diffuses into 
the tumor bed through the leaky vasculature and EPR effect, reaching the nucleus and 
halting cell division.  
 This approach exploits albumin’s properties and receptors and leverages the 
SPARC interaction for cell death of tumor cells, and while the gp60 receptor is 
overprolifferated on tumor cells’ surfaces, this mechanism is arguably not well 
understood. It should be noted that the lungs and heart have a substantial amount of gp60 
receptors present.75-78 Clinical trials have proven that Abraxane is not found in these areas 
in a substantial concentration.66, 72-74, 80 Regardless, albumin-bound paclitaxel has pushed 
the frontiers of nanomedicine in the treatment of cancer. There are, however, 
opportunities present for optimization, improvement, and further exploitation of 
albumin’s properties and the body’s natural mechanisms of particle uptake. 
 Due to the fact that Abraxane is not one covalent entity, the bound mixture has a 
finite stability. It is said that albumin contains a hydrophobic pocket, where paclitaxel 
may likely reside. However, the hydrogen bonds and van der Waals forces over time 
become over ridden by other driving forces and paclitaxel becomes disassociated from 
albumin. Once reconstituted, Abraxane is stable for a few hours at room temperature in 
aqueous continuous phases. It forms spheres with diameters ranging from 50 to 150 nm. 
Albumin typically readily dissolves in aqueous systems. In the case of Abraxane, the 
albumin fraction remains associated with paclitaxel at first. After a few hours, the 
albumin-solvent interaction surpasses the albumin-paclitaxel association and forces the 
paclitaxel to become disassociated from the albumin. The disassociation effect is 
catalyzed at higher temperatures. It is possible that this dissociation occurs partially in 
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circulation, before particles can reach gp60 receptors on vascular endothelial cell, 
creating the cytotoxic drug premature release and affecting unwanted toxicity issues 
responsible for undesired side effects of chemotherapy, such as peripheral neuropathy. 
Free paclitaxel will readily permeate cell membranes and thus needs to be protected 
before arriving at tumor cells.81, 82 Stability investigations were of great interest to see if 
the PRINT technology could enhance properties and increase efficacy for treating cancer 
using Abraxane. 
 
 
3.4.1.2 Characterization 
 3.4.1.2.1 Materials. Abraxane (Abraxis BioScience, Inc. and AstraZeneca) was 
obtained from the UNC Hospital pharmacy and handled with extreme caution. Sodium 
chloride was used to create a 0.9 weight percent solution in water to produce saline. Ultra 
pure (17 MΩ), deionized water was used throughout. 
3.4.1.2.2 SEM. Scanning electron microscopy (SEM) (Hitachi model S-4700) 
was used to analyze dry and reconstituted Abraxane.  Samples were placed on a glass 
slide and were coated with 1.5 nm of Pd/Au alloy using a Cressington 108 auto sputter 
coater (Cressington Scientific Instruments Ltd.).  The Pd/Au coated glass slide was then 
adhered to the sample holder using double-sided adhesive tape, and placed inside the 
vacuum chamber of the SEM and observed under low vacuum (10-3 Torr). SEM analysis 
of dry and reconstituted Abraxane illustrates the non-uniformity of this product (Figure 3-
5). Dispersity in size and shape of this product are evident as shown in the SEM 
micrographs (Figure 3-6).  
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Figure 3-5. SEM of Abraxane as received. 
 
   
Figure 3-6. SEM micrographs of Abraxane reconstituted to 50 mg/mL in water. (Image 
taken one hour after preparation). 
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3.4.1.2.3 DLS. Dynamic scattering studies were performed using a 90Plus Particle 
Analyzer (Brookhaven Instruments) with 30 mW laser source.  Data collection was 
performed at a detection angle of 90o and typical sample volume of 2 mL.  The 
experiment temperatures were controlled by the heating system integrated inside the 
90Plus.  The scattering data of the samples was analyzed by Cumulant analysis to obtain 
polydispersity, and by COTIN and NNLS methods to obtain size and distribution.  
Samples of DLS experiments were dissolved in distilled water or saline (equal to 0.9 wt% 
NaCl in water) solutions at concentrations from 0.01 to 1 mg/mL.  To minimize dust 
interference and to obtain accurate measurements, all solutions were freshly prepared.  
 Five milligrams of Abraxane was dissolved in 100 mL saline solution to obtain a 
concentration of 0.05 mg/mL.  Two millilitres of the Abraxane solution was placed inside 
a cubic light scattering cell. DLS experiments were initially performed at 25 oC.  The 
solvent refractive index was set to water. The dust cut off ratio was 80%.  The experiment 
duration time extended one minute. Each sample was measured five times.  
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Figure 3-7. Dynamic light scattering analysis of Abraxane solution at room temperature. 
 
Figure 3-7 illustrates that upon reconstitution, Abraxane forms particles consisting 
of a size just below 150 nm. Though it is not extremely broad, some polydispersity exists 
in the sample, in the range of 0.2. 
A fresh solution at the same concentration as above was prepared to investigate the 
size and dispersion of reconstituted Abraxane at physiological temperature. Two 
millilitres of Abraxane solution was placed inside a cubic light scattering cell. The 
temperature controller of the DLS was programmed for 37 oC.  Once the cuvette reached 
equilibrium at 37 oC, the DLS experiment was conducted.  The solvent refractive index 
was set as water and dust cut off ratio was 80%.  The experiment duration time lasted one 
minute and each sample was measured five times.  
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Figure 3-8. Dynatic light scattering analysis of Abraxane solution at physiological 
temperature. 
 
The size and dispersity of reconstituted Abraxane at physiological temperatures is 
shown in Figure 3-8. It is apparent that the stability of Abraxane particles is present at 
least initially at higher temperatures. The stability of reconstituted Abraxane was 
monitored over time using DLS analysis and investigated the effect of temperature and 
solvent over time. Studies investigating reconstitution of Abraxane is water versus saline 
showed little difference in stability. Ions is saline may promote the disassociation of 
Abraxane particles compared to water, but clear effects are more pronounced looking at 
temperature, as one might expect. It is clearly stated in the directions that once a dose is 
reconstituted, one has a limited amount of time for administration. This is likely due to 
disassociation of the paclitaxel from the albumin as solvent interactions override any 
binding forces that may keep paclitaxel temporarily bound to albumin. As one might 
expect, this stability decreases sooner at higher temperatures. At physiological 
temperatures, reconstituted Abraxane remains stable for three hours before complete 
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dissolution. One can clearly see in Figure 3-12 and Figure 3-13 that the size versus time 
and the polydispersity versus time show dramatic change at or after three hours. The 
infusion time for a patient, though significantly reduced from previous products, is still 
30 minutes. This impacts potential side effects and whether with circulation time all of 
the drug can arrive at the tumor bed before disassociation. Additionally, reconstituted 
Abraxane particles range from 50 to 150 nm is diameter. The disassociation of the 
smaller particles may likely be different compared to the larger spheres due to the surface 
area of the particle exposed to solvent. Though Abraxane has overcome major challenges 
in delivering paclitaxel and has improved toxicity levels, decreased undesired side effects 
in peripheral neuropathy, shortened infusion length times, and identified a targeting 
strategy by exploiting the properties and characteristics of albumin and tumor 
mechanisms in obtaining nutrients, the benefits are capable of being extended with the 
fabrication of an Abraxane-like particle having shape and size specificity and 
monodisperseness. 
 
 
3.4.2 Abraxane-PRINT Efforts. 
 3.4.2.1 Fabrication. Commercially available Abraxane was purchased from the 
University of North Carolina Hospital Pharmacy. Great caution was taken when handling 
Abraxane. For greater ease in handling the lyophilized powder was aliquoted into 
multiple, pre-weighed (tared) eppendorf tubes in a glove bag under positive nitrogen 
pressure. Aliquots were stored covered in a desiccator in the glove bag. Samples 
(eppendorfs) were taken out of the desiccator under positive nitrogen flow just prior to 
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use. Individual eppendorf samples were weighed and the amount of Abraxane contained 
was calculated by subtracting the eppendorf’s tare weight. Each sample of lyophilized 
powder was reconstituted in water to make a 25 % by weight solution. This mixture was 
vortexed until all Abraxane was dissolved. An opaque, stable solution was obtained. This 
solution was used with the time frame indicated in the instructions prior to infusion and 
otherwise properly disguarded. This solution was then used to fabricate PRINT particles. 
Similar to fabricating PVP particles, a master template was first fabricated by selectively 
etching a pattern generated by photolithography into a silicon substrate to yield a densely 
packed micro- or nano-sized features on a two-dimensional array (Figure 3-9A). A 
fluorocarbon elastomeric mold was created by pouring a photochemically curable 
telechelic perfluoropolyether (PFPE)18, 23 onto the patterned master templates and curing 
it while in contact with the master template to yield a patterned PFPE PRINT mold 
containing the corresponding 200 nm features as cavities (Figure 3-9B). Nanomolding of 
Abraxane was achieved by a lamination technique where the aqueous Abraxane solution 
was placed between the patterned PFPE mold and another film (counter sheet) having a 
higher surface energy (Figure 3-9C).  In this particular case a polyethylene sheet was 
used as the counter sheet during the PRINT lamination process. The PFPE mold, aqueous 
protein solution and polyethylene sandwich structure was passed through a roller with an 
applied pressure of 50 psi, higher than what was used for PVP particles. The applied 
pressure was needed to help spontaneous filling of the cavities since aqueous solutions 
have a higher surface energy than most organics. As the mold passes under the roller the 
high energy film was peeled away leaving a filled mold of individual cavities containing 
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the aqueous protein solution without the formation of a flash layer between each filled 
cavity. The filled mold is subsequently frozen and lyophilized overnight     
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Figure 3-9. Illustration of PRINT process to make nanomolded Abraxane particles. 
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3.4.2.2 Characterization. 
3.4.2.2.1 SEM. The size of nanomolded Abraxane PRINT nanoparticles was 
analyzed via scanning electron microscopy (Hitachi model S-4700).  Particles were 
harvested onto PET or a glass slide and were coated with 1.5 nm of Pd/Au alloy using a 
Cressington 108 auto sputter coater (Cressington Scientific Instruments Ltd.).  The Pd/Au 
coated PET was then adhered to the sample holder using double-sided adhesive tape, and 
placed inside the vacuum chamber of the SEM and observed under low vacuum (10-3 
Torr).  
 Figures 3-10 and 3-11 illustrate SEM micrographs of nanomolded Abraxane 
PRINT particles. The left SEM micrograph of Figure 3-10 shows 200 nm (diameter) x 
200 nm cylinders harvested wet onto a poly(ethylene terethalate) sheet. The right image 
of Figure 3-10 reflects particles of the same size harvested using a glass slide, gentle 
mechanical force and a drop of chloroform to lift particles from the PFPE mold. The two 
SEM micrographs of Figure 3-11 illustrate particles of 200 nm (diameter) x 600 nm 
cylinders harvested in the same fashion as the latter example. Uniform, monodisperse 
particles, of different aspect ratios composed of Abraxane was successfully fabricated. 
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Figure 3-10. SEM micrographs of nanomolded Abraxane PRINT particles. 
 
  
Figure 3-11. SEM micrographs of nanomolded Abraxane PRINT particles. 
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 3.4.2.3 DLS. Solutions of Abraxane and nanomolded Abraxane PRINT particles 
of the same concentration were analyzed using DLS at physiological temperature. 
Investigating the size distribution and the polydispersity showed similar results. As 
expected, Abraxane’s stability (mean size at 130 nm and low polydispersity) drastically 
dropped off after two hours. The size data suggests that after two hours the favorable 
dissolution characteristics of albumin into saline override the binding forces of paclitaxel 
in albumin clusters. The larger spheres start to dissolve as the strongest DLS size 
population is below 50 nm. The polydispersity data in conjunction illustrates that after 
two hours the disperisity value dramatically increases, suggesting multiple size 
populations, and thus lesser stability of the product. 
 Nanomolded Abraxane PRINT particles of 200 nm (diameter) x 200 nm cylinders 
show increased stability with respect to size and polydispersity, out to at least eight hours. 
One hypothesis to explain this phenomenon is that these particles are monodisperse in 
size and shape and thus have the same surface area exposed to solvent. The PRINT 
process also enables consistency in the ratio of paclitaxel to albumin. The fabrication 
technique may also improve the binding forces that hold paclitaxel bound to albumin 
together due to the high concentration utilized in the PRINT process. The proprietary 
coascervation process used to fabricate Abraxane particles is extremely dilute. It is 
possible that this creates only loosely bound paclitaxel to albumin (stable for two hours), 
relative to the binding farces created from the PRINT process. 
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Figure 3-12. Size and stability of reconstituted Abraxane and PRINT particles. 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10
P
ol
yd
is
pe
rs
ity
time [h]
Abraxane 200x200 nm
Abraxane reconst
 
Figure 3-13. Polydispersity and stability of reconstituted abraxane and PRINT particles. 
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3.4.3 Summary and Future Efforts. Nanomolded Abraxane PRINT particles 
illustrate longer stability at physiological conditions which may increase the therapeutic 
efficacy and decrease undesired side effects. Initial cytotoxicity studies using 3T3 
Fibroblast cell were conducted comparing free Abraxane, 200 nm (diameter) x 200 nm 
cylinders of nanomolded Abraxane, free albumin, nanomolded albumin, and free 
paclitael at the same relative concentration of paclitaxel. Initial results looked promising. 
The nanomolded Abraxane particles were killing more cells than Abraxane or paclitaxel 
alone at the same relative concentration. Unfortunately, negative controls in albumin 
particles showed some toxicity. After once repeating these experiments and obtaining 
similar results, efforts were halted to pursue protein PRINT particle fabrication and 
investigations thereof. Future directions of this work could include carefully repeating 
cell dosing experiments and monitor call viability. The cytotoxicity levels of nanomolded 
Abraxane PRINT particles in comparison to Abraxane should be investigated using a 
different cell line as well. Different size and shape particles should be investigated for 
nanomolded Abraxane and albumin. It is possible that harvesting methods need to be 
varied to overcome any introduced toxicity, not otherwise incurred by the particle matrix 
as with albumin. Ultimately, in vivo studies in healthy and in tumored mice are 
warranted. These studies would investigate the maximum tolerated dose of the 
therapeutic and compare Abraxane to nanomolded Abraxane. Within tumored mice 
studying the time line of tumor regression and present of relapse would be of tremendous 
value. As the PRINT technology develops particle sizes and shapes ideal for treatment of 
cancer, nanomolded Abraxane may show significant utility in the role to fight cancer and 
become the newest gold standard therapeutic. 
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NANOMOLDING SHAPE- AND SIZE-SPECIFIC PROTEIN PARTICLES 
USING THE PRINT TECHNOLOGY 
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4.0 Introduction. 
4.1 PRINT Technology Enabling Nano-Fabrication of Shape-Specific, Monodisperse 
Protein Particles. Protein particles are at the forefront of a surge in research and 
development for enhanced therapeutics and are being utilized as powerful drug delivery 
vectors, to overcome solubility concerns, or being realized as the key therapeutic in often 
invasive treatment regiments.  Handling and storage protocols of these sensitive materials 
have proven to be challenging at times due to the susceptible nature of these liable 
biologics. Storage needs are pertinent in this field and much effort has been dedicated to 
investigations of the variables and parameters that effect biological efficacy such as 
temperature, moisture, formulation, particle fabrication method, and composition.  A 
need for a facile, robust technique to store and handle therapeutic proteins remains 
unmet. Recent drive for attaining discrete control over particle shape, size, dispersity, and 
surface interaction for drug delivery has proven essential particularly in targeted cancer 
research. Additionally, these methods are not robust and slight variation of any parameter 
in the fabrication process greatly affects the stability and overall outcome of the desired 
product.1-4 The PRINT™ technology (Particle Replication In Non-Wetting Templates) 
offers a broad platform for the facile fabrication, handling, and storage of protein 
particles that remain un-aggregated until just prior to use. This versatile methodology 
lends itself to easy scale-up and avoids any loss of monomer or degradation of the 
protein. No surfactants, stabilizing agents, co-solvents, or co-monomers are necessary for 
the protein particle delivery vector. The PRINT process enables a gentle, facile route to 
non-disperse particles of 100 percent protein as small as 200 nm cylinders. 
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 Rolland et al reported in 2004 the exploitation of the excellent solvent resistance 
and inherent release properties of perfluoropolyether (PFPE) elastomers as a molding 
material for soft lithography. When molding onto a non-wetting surface the fabrication of 
individual particles is realized, in contrast to traditional soft lithography techniques that 
typically create embossed films having a residual or flash layer interconnecting the 
features. PRINT uses the non-wetting characteristic of PFPE-based elastomers to 
generate high-resolution micro- and nano-meter sized objects that are free of the 
interconnecting flash layer, creating arrays of discrete particles or features. The 
fabrication of “smart particles” with independent control over size, shape, composition, 
cargo encapsulation, surface functionality, and biodistribution5 have been achieved using 
the PRINT technology. PRINT is capable of generating shape-specific, mono-disperse 
nanoparticles composed of a variety of materials including synthetic polymers, hydrogels, 
and active pharmaceutical ingredients.6, 7 The gentle nature of this process allows for 
particle fabrication of even delicate biologics such as proteins. In this chapter the first 
account of unique protein particle fabrication of discrete size and shape. These protein 
particles and mono-disperse and non-aggregated. The fabrication process is conducted 
with high fidelity and precision. The physical and functional characterization of the 
fabricated protein particles were conducted using SEM, ELISA, DSC, FTIR, and 
fluorescence. The work is reported using albumin as a model protein and shows 
preliminary work for numerous other proteins including insulin, hemoglobin, transferrin, 
interferon-beta, trypsin, horseradish peroxidase, and IgG polyclonal antibody.  
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4.2 Importance and Implication of Proteins in Disease Fighting, Biomarkers, and 
Targeting Ligands. As discussed to in section 3.4, proteins encompass bio- and 
nanotechnologies, which are ever-growing and interrelated research fields with billions of 
dollars being invested in the development and improvement of state-of-the-art 
therapeutics,8 delivery vectors, imaging agents,9, 10 biosensors,11, 12 devices, coatings, and 
other biomedical applications.13 Biomolecules and protein particles are leading this surge 
in research and development of enhanced therapeutics. They are being utilized as 
powerful targeting ligands, drug delivery vectors, and as the key therapeutic in invasive 
treatment regiments.  Handling and storage protocols of these sensitive materials have 
proven to be challenging at times due to the susceptible nature of these labile biologics. 
Storage demands are pertinent in this field and much effort has been dedicated to 
investigating the effects of numerous parameters such as temperature, humidity, 
composition, and fabrication method in order to retain the protein’s native state and 
biological function.  Much attention has been dedicated to attaining and investigating 
effects of judicious control over particle shape, size, dispersity, and surface interaction 
for targeted drug delivery and has emerged as essential, particularly in cancer research.14-
21 However, current state-of-the-art methods for developing mono-disperse, discrete size 
and shape particles comprised of proteins have not been successful or are not robust and 
slight variations in parameters of the fabrication process can greatly affect the stability 
and overall outcome of the desired product. Hence, until now the need for a facile, robust 
technique to store and handle therapeutic proteins has remained unmet. 
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4.3 How Protein Particles are Typically Prepared. Protein particles are often made 
through complicated processes which include wet-milling, spray-freeze-drying,1, 4, 22-27 
micro-emulsion,28 micro-encapsulation,2, 29-34 or super critical fluid29, 35, 36 methods. These 
procedures result in highly disperse particle sizes in the tens of microns are strictly 
spherical, and tend to aggregate. Protein particles are typically stored as a lyophilized 
powder. Studies are increasingly showing the size, shape, and dispersity have a 
tremendous impact on biological processes.15 Most manufacturing processes are also 
dependent on very strict parameters and precise control of conditions, some of which 
strongly influence the product outcome and often induce stresses leading to denaturation. 
Size, morphology, and stability of these proteins have tremendous implication on the 
outcome and efficacy of various bio-pharmaceutical applications.  
Proteins require their native structure not to be significantly disrupted in order to 
be biologically active, thus maintaining their conformation is crucial in developing 
protein pharmaceuticals.25 However, due to the inherent frailty of these biomaterials a 
variety of intra- and intermolecular chemical reactions are capable of irreversibly 
perturbing their native structure and thus rendering them biologically inactive. The 
approach to particle fabrication composed of proteins requires a gentle process which will 
not disrupt the protein’s activity, affecting its potential use in biopharmaceuticals.  
Recently, techniques used by the microelectronics industry to fabricate patterns 
on the micro- and nano-scale have been adopted by the life sciences for patterning,37-39 
particle fabrication,40 and crystallization41, 42 of a wide range of biologically-relevant 
materials.43 However, a significant improvement in the methodologies used in this field is 
required because proteins are extremely sensitive compounds that are easily denatured or 
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degraded. Engineered protein particle fabrication with control over shape and size that 
preserves biofunctionality has not been realized to date.   
 
4.4 Nanomolding Proteins. 
 4.4.1 Fabrication Methodology and Variables. The fabrication of protein 
PRINT particles is achieved similarly to nanomolded Abraxane, as discussed in Chapter 
3. Due to the sensitive nature of proteins and biologics, extreme care must be taken in 
fabricating shape- and size specific, monodisperse micro- and nanoparticles. External 
stimuli such as heat and UV irradiation often affect biomaterials detrimentally and alter 
their integrity, functionality, and bioavailability. Additional concerns within the 
fabrication methodology include concentration-dependant denaturation and choice of 
continuous phase with proteins in solution. Variables of the fabrication process 
investigated included protein concentration, solvent/buffer choice for protein 
reconstitution prior to nanomolding, speed of laminator stage, material of counter sheet, 
pressure of roller and thus counter sheet, and harvesting methods. Best results were 
obtained in most cases when 25 weight percent protein in water was nanomolded at 
relatively low stage speed, 50 psi applied pressure, using poly(ethylene terethalate) as a 
counter sheet, and utilizing a harvesting film or excipient to extract particles from the 
mold.  Directly harvesting with water or buffer also collects protein particles from the 
mold (Figure 4-1). 
 
 4.4.2 Protein Choice for Investigation. Albumin was chosen as the model 
protein due to the extensive citing in literature including its use as a delivery vector,43-45 
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exploitation of its receptor (gp60),46 and protein conjugate systems.47-49 Additional 
biomaterials were investigated for their clinical importance and to gage the breadth and 
gentleness of the PRINT process with therapeutic proteins and enzymes. Insulin, 
tranferrin, hemoglobin, IFN-beta, trypsin, HRP, and IgG differ greatly in molecular 
weight, crystallinity, and solubility in water. Insulin was chosen for its importance in the 
treatment of diabetes and the potential enhancement of a pulmonary drug delivery 
system. Much work has been dedicated to better delivery systems and methods of insulin 
for treatment of diabetes.50-54 Interferon-beta possesses anti-inflammatory properties and 
has been shown to improve the integrity of the blood-brain barrier in multiple sclerosis 
(MS) patients. Commercial interferon-beta-based drugs are typically sold in two 
formulations, a lyophilized powder requiring reconstitution and a pre-mixed liquid 
syringe kit, which is administered via an intramuscular injection. Hemoglobin is an 
important oxygen carrier in the body and plays a crucial role in iron-deficiency anemia 
and sickle-cell disease. Transferrin has recently made an impact as a targeting ligand and 
is implicated in the transport of iron.  
Enzymes as a whole perform an all-encompassing function in the development 
and maintenance of the human body and are being utilized for disease treatment and 
prevention. Trypsin is a serine protease enzyme found in the digestive system and is used 
in biotechnological processes with implications in the treatment of cystic fibrosis. 
However, when its break-down of other proteins runs unchecked, it can lead to pancreatic 
and cellular diseases. Horseradish peroxidase has been shown to improve marking 
neurons and to amplify biotechnical analyses in the field of neuron biology. Many others 
are finding opportunities in treatments for cardiovascular disease (Natrecor, GPIIB 
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receptor, protein G receptor), HIV (Interferon, Somatostatin, T20, T1249, IL-2), 
inflammation (TNF-α, IL1-RA), Alzheimer’s disease (antisense, laminin), Crohn’s 
disease, and cancer (interferons, monoclonal antibodies).  
 
 4.4.3 Methods. 
4.4.3.1 Materials. Fluorocur™  and untreated PET sheets were purchased from 
Liquidia Technologies. An ELISA starter kit and standard sandwich ELISA kits for 
human albumin, hemoglobin, and transferrin was purchased from Bethyl Laboratories. A 
sandwich ELISA kit for human insulin was purchased from CalBiotech. Human albumin, 
hemoglobin, transferrin, insulin, and recombinant rat interferon-β were purchased from 
Sigma Aldrich as lyophilized powders. Trypsin, horseradish peroxidase, N-benzoyl- L-
arginine-nitroanalide, hydrogen peroxide, pyrogallol, and D(+)-trehalose was purchased 
from Sigma Aldrich and used as received. Ultrapure 17 mega Ohm water was filtered 
through a 0.22 µm Millipore PES membrane. PBS (1x) was used for harvesting and 
various characterizations. Rhodamine B was purchased from Acros Organics and used as 
received. With a target sequence of N.N.G.A.U.U.A.U.G.U.C.C.G.G.U.U.A.U.G.U.A 
and an antisense sequence of 5’-P.U.A.C.A.U.A.A.C.C.G.G.A.C.A.U.A.A.U.C.U.U, 
siRNA was purchased from DHARMACON as a 2.0 µmol lyophilized powder. Standard 
laboratory practices when handling RNA including decontamination were conducted. 
Poly(vinyl pyrrolidone), avg MW 58000 g/mol, was purchased from Acros Organics and 
dissolved in water to create a 10 % by weight solution, used as a harvesting film. 
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 4.4.3.2 Fabrication of Protein PRINT™ Particles. The preparation of patterned 
Fluorocur has been described elsewhere. Briefly, inside an enclosed UV chamber 20 mL 
of Fluorocure with 0.1 % of 2,2-diethoxyacetophenone was cast onto an eight inch 
patterned master (feature sizes ranging between master template cavity sizes of 200 nm 
and 5 µm). After complete spreading of the Fluorocur, the UV chamber was purged with 
nitrogen for five minutes and subsequently irradiated (λ=365 nm, power < 20 mW/cm2) 
to cure the Fluorocur resin with ongoing purge for three minutes. The fluorinated 
elastomer was then gently peeled from the silicon master. The elastomer was then placed 
on a stage. A sandwich structure of the PFPE mold, aqueous protein solution and a high 
energy counter sheet, in this case a polyethylene film, was slowly moved through a roller. 
As the mold passed through the roller, the high energy counter sheet was peeled away 
from the sandwich structure, leaving the mold filled with no interconnecting flash layer.  
Pressure was applied to the roller, typically 50 psi. The aqueous protein solution was 25 
wt % in ultrapure water, unless stated otherwise. In the case of insulin, a 4 wt % aqueous 
solution was prepared and added to the sandwich structure for nano-molding. In the case 
of IFN-beta, a 10 wt % aqueous solution was prepared. Filled molds were frozen and 
lyophilized. Particles were harvested directly using a glass slide with minimal pressure 
and a drop of a non-solvent, typically chloroform or with PBS for further analysis. 
Particles were harvested in an array onto medical grade poly(cyanoacrylate) or an 
excipient film (poly(vinyl pyrrolidone). In this case, a drop of the harvesting solution is 
placed onto a substrate, usually a glass slide or in the case of ELISA in the bottom of a 
well in a 96-well polystyrene plate. The filled mold is rolled onto the drop. Once dry, the 
elastomer is peeled from the substrate, and particles adhere to the substrate. 
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 4.4.3.3 SEM. The size of PRINT nanoparticles was analyzed via scanning 
electron microscopy (Hitachi model S-4700).  Particles were harvested onto PET and a 
thin film of 10 wt % Povidone in water and were coated with 1.5 nm of Pd/Au alloy 
using a Cressington 108 auto sputter coater (Cressington Scientific Instruments Ltd.).  
The Pd/Au coated PET was then adhered to the sample holder using double-sided 
adhesive tape, and placed inside the vacuum chamber of the SEM and observed under 
low vacuum (10-3 Torr).  
 
4.4.3.4 ATR-FTIR. ATR-FTIR analysis was performed with a Tensor 27 FTIR 
instrument (Bruker) using a Hyperion microscope fitted with an ATR objective with a Ge 
crystal as the internal reflectance element (IRE) and a MCT detector.  OPUS software 
was employed for data processing. FTIR spectroscopy was used to investigate the 
presence of functional groups and the amide I region (1500 to 1700 wavenumbers) and 
establish qualitative secondary structure information of free lyophilized albumin and 
lyophilized albumin PRINT particles. 
 
4.4.3.5 CD. Protein solutions were prepared at a final concentration of 0.1 mg/mL 
in 16.7 MΩ deionized water. PRINT protein samples were nano-molded, lyophilized in 
the mold, harvested directly into water, and lyophilized again. Five micron cube PRINT 
particles were fabricated for CD analysis. Data was collected on an Applied Photophysics 
Pistar-180 Circular Dichroism, at 25 C, with a 1 mm path length cell, a 15-nm/min scan 
rate and a 2 nm bandwidth. Spectra were an average of 25 scans from 185 to 260 nm. A 
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spectrum of water was collected and subtracted from the protein samples. Protein 
samples were run in triplicate.  
 
4.4.3.6 BCA. Standard BCA protocol was followed in order to determine protein 
sample concentrations. Bovine albumin (BSA) standards were always prepared fresh for 
each assay. All samples were analyzed with n=3. After addition of reagents to a 96 well 
plate, standard or enhanced assays were conducted for the respective BSA working 
concentration ranges. Incubation for 30 min at 37 °C for the standard protocol and 30 min 
at 60 °C for the enhanced assay was conducted. After cooling to room temperature 
absorption of the plate was analyzed at 562 nm. Average OD values for the BSA 
standards were plotted versus concentration. A linear trend line was fit to the data. The 
equation of the trend line was used to solve for the concentrations of the unknown protein 
solutions.  
   
4.4.3.7 Fluorescence Microscopy. Relative fluorescence intensity of the 
tryptophan residue in albumin was measured as a function of concentration in PBS at an 
excitation wavelength of 280 nm and an emission wavelength of 348 nm in a black plate. 
Concentrations of the free and PRINT protein solutions were analyzed prior to 
fluorescence measurements using a BCA assay. Black 96-well plates were used in a plate 
reader. 50 uL solution was added to each well. Each sample was measured at least in 
triplicate. 
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4.4.3.8 ELISA. Standard sandwich ELISA assays were conducted unless 
otherwise stated. A typical sandwich ELISA protocol was followed to accommodate a 96 
well-plate. Detection antibodies were polyclonal and HRP conjugates. Kit standards were 
added in the concentration range that was recommended and diluted as suggested with 
sample diluents provided in the ELISA starter kit. Free and PRINT protein samples were 
diluted such that four concentrations being investigated were in the linear range. The 
HRP conjugate dilutions were twice as concentrated as the starting recommendation, but 
well within the working range i.e. if the recommended dilution was 1:100,000, the actual 
dilution used was 1:50,000. In the case of insulin, a coated plate with capture antibody 
was used as received. Substrate solution was added just prior to use and allowed to warm 
to room temperature. Once adequate color was observed, 2M H2SO4 was added as 
stopping solution. Absorbance was measured with a SpectraMax M5 plate reader 
(Molecular Devices) at 450 nm. 
 
4.4.3.9 Enzymatic Activity Assay. Standard protocols were followed at room 
temperature to measure the enzymatic activity of trypsin and HRP, respectively. In the 
case of HRP, the substrates used were hydrogen peroxide and pyrogallol, and absorbance 
was measured at 450nm every 20 seconds for five minutes. HRP concentrations ranged 
from 2.5 ug/mL to 0.63 ug/mL in PBS. In the case of trypsin, the catalytic hydrolysis of 
N-benzoyl- L-arginine-nitroanalide was monitored in phosphate buffer. Trypsin 
concentrations ranged from 1 mg/mL to 0.25 mg/mL in PBS. The absorbance was 
measured at 380 nm every 20 seconds for five minutes. Enzyme concentrations were 
chosen such that after five minutes the OD at the respective wavelength was close to 1. 
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Measurements were taken of solutions in a quartz cuvette using a UV-vis 
spectrophotometer. Substrate solution was mixed by inversion and used as the reference. 
Enzyme solution was added to the cuvette and inverted five times before starting a kinetic 
analysis of absorbance. In the case of trypsin, enzyme solutions were prepared just prior 
to characterization and kept on ice. 
 
4.4.4 Results. 
4.4.4.1 Albumin. 
4.4.4.1.1 Fabrication of Nanomolded Albumin PRINT Particles. A master 
template was first fabricated by selectively etching a pattern generated by 
photolithography into a silicon substrate to yield a densely packed micro- or nano-sized 
features on a two-dimensional array (Figure 3-9A). A fluorocarbon elastomeric mold was 
created by pouring a photochemically curable telechelic perfluoropolyether (PFPE) onto 
the patterned master templates and curing it while in contact with the master template to 
yield a patterned PFPE PRINT mold containing the corresponding different features as 
cavities (Figure 3-9B). Molds from masters including 200x200 nm cylinder, 2x2x4 µm 
square post, 3x3x3 µm cubes, 5x5x5 µm cubes, 10 µm boomerangs, and 3 µm hex nuts 
were fabricated for use in protein PRINT™ particle production.  Nano-molding of protein 
particles was achieved by a lamination technique where an aqueous protein solution, 
typically 25 wt % protein in water, was placed between the patterned PFPE mold and 
another film (counter sheet) having a higher surface energy (Figure 3-9C).  In this 
particular case a polyethylene sheet was used as the counter sheet during the PRINT 
lamination process. The PFPE mold, aqueous protein solution and polyethylene sandwich 
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structure was passed through a roller with an applied pressure of 50 psi. As the mold 
passes under the roller the high energy film was peeled away leaving a filled mold of 
individual cavities containing the aqueous protein solution without the formation of a 
flash layer between each filled cavity. The filled mold is subsequently frozen and 
lyophilized overnight to remove the majority of the water (Figure 3-9D). Protein particles 
were harvested directly by gently moving a drop of a polar non-solvent such as 
chloroform across the mold.  Harvesting the protein particles in the form of a two 
dimensional array on a film, such as medical adhesive grade poly(cyano acrylate) or on 
an excipient film such as Povidone™ (poly(vinyl pyrollidinone)), was achieved by first 
casting a uniform thin film of the harvesting layer onto a glass slide using a Meyer Rod 
(Figure 3-9E).  Then the patterned PFPE mold containing the protein particles was run 
through a roller, pattern side down, onto the liquid harvesting film (Figure 3-9F). Once 
the harvesting film was dried (in the case of using a Povidone harvesting film) or 
polymerized (if using the cyano acrylate harvesting film), the filled patterned mold was 
peeled away from the harvesting film to yield a two-dimensional array of protein 
particles (Figure 3-9G).  During this harvesting step, the protein particles were transferred 
from the patterned PFPE mold onto the harvesting film in an essentially quantitative 
manner. By dissolving the harvesting film, individual protein particles could be collected 
(Figure 3-9H). 
Albumin PRINT particles were fabricated in a similar method as to nanomolded 
Abraxane PRINT particles. Lyophilized human albumin was purchased from Sigma 
Aldrich and used as received. Albumin was added to filtered, 18 MΩ water to create a 25 
weight % solution. In the case of albumin with cargo, dye or siRNA was added before the 
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addition of water. A PFPE mold was made from pouring and curing onto an etched 
silicon wafer and used in a sandwich structure with a 25 % by weight of albumin in water 
and a high energy counter sheet, again in this case PET. More concentrated solutions are 
capable of creating albumin PRINT particles including 30 and 35 % by weight in water. 
The sandwich structure was passed under a roller with an applied pressure of 50 psi. As 
the structure passed under the roller the PET sheet is peels away, leaving discrete cavities 
of the PFPE mold filled with a concentrated albumin solution. Some of the water may be 
driven off in the molding process. The filled mold is frozen and lyophilized to ensure 
total removal of water. This last step is also conducted for quality control, as most protein 
particle fabrication processes include a lyophilization step. Additionally, I felt that 
lyophilizing the PRINT protein particles would give a more direct comparison to 
lyophilized free protein as received. 
 A number of studies were explored with albumin. Harvesting methods were 
examined. Harvesting onto thin film adhesives resulted extremely feasible. Sipper 
harvesting with a non-solvent was considered. The choice of solvent utilized for sipper 
harvesting was scrutinized as it should not dissolve the particles, but also not denature the 
labile protein. Chloroform resulted in discrete, free flowing particles as indicated by SEM 
analysis.  However, upon reconstitution in water the entire product did not seem to 
redissolve potentially indicating irreversible denaturation had occurred. Exhaustive 
drying may not have occurred, leaving a thin layer of chloroform around the albumin 
particles. This would create challenges for water to have clear access to the albumin for 
dissolution. It has been noted that cold ethanol is used to precipitate albumin from whole 
serum without denaturing albumin. Future investigations to use cold ethanol with sipper 
 146
harvesting methods could lead to free flowing, discrete protein particles, which can be 
fully reconstituted, would be of interest. 
Cargo encapsulation was investigated by adding siRNA to the aqueous albumin 
solution prior to nanomolding. Since the compound was received in as a lyophilized 
powder, an aliquot was reconstituted in water. Due to cost, little antisense was used. 
Loading amount was close to 0.5 %. Visual conformation of cargo encapsulation was 
indicated by the magenta color (as a result of the antisense) of the molding solution and 
after harvesting, of the particles. Particles were harvested on a thin layer of medical grade 
adhesive. Dissolution of albumin particles was also monitored by adding a water-soluble 
dye, rhodamine B, to the composition. This mixture was nanomolded and particles were 
harvested onto Povidone, a water soluble adhesive film previously described. For this 
study particles of 5 µm cubes were fabricated, such that the dissolution study could be 
easily monitored using fluorescence microscopy.   
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 4.4.4.1.2 SEM and Fluorescent Microscopy. Scanning electron microscopy was 
used to analyze the size and shape of all protein particles. Figures 4-1 through 4-6 
illustrates albumin particles of different size, shape, and harvesting methods. These 
micrographs confirm the consistent nature of the PRINT process enabling facile 
fabrication of uniform, shape-specific, monodisperse particles composed of any protein. 
 Figure 4-1 illustrates albumin nano- and microparticles harvested on thin film 
adhesives and Figure 4-2 contains micrographs of directly harvested albumin particles of 
200 nm cylinders using chloroform. Figure 4-3 and 4-4 illustrate SEM micrographs 200 
nm cylinder particles of albumin with 0.5 % siRNA and gadolinium oxide loading, 
respectively. Discrete, uniform size and shape specific nanomolded albumin particles 
were fabricated as illustrated in the SEM micrographs. Particle sizes around or below 200 
nm are thought to be of a therapeutic size range. The breadth of the PRINT process 
within fabricating different sizes was investigated by attempting the fabrication of larger 
sized cubes, up to 5 micron as illustrated in Figure 4-5. 
Five micron particles were fabricated composed of albumin and a small weight 
fraction of rhodamineB, a non-covalently linked, water soluble dye. This size allows for 
facile analysis and monitoring using optical microscopy. The dye allows for additional 
increased image quality by using fluorescence microscopy in the red channel. Dissolution 
of the fabricated PRINT particles was investigated. The effect of the PRINT process on 
the protein’s state can qualitatively be studied with dissolution.  Denaturation often 
results in aggregated or polymerized protein that remains insoluble in water. Five micron 
particles composed of albumin and dye were harvested on Povidone. Figure 4-6 
illustrates optical and fluorescent images of five micron particles before, during, and after 
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addition of water to monitor dissolution. The last two images clearly show dissolved 
particles as the dye is evenly distributed across the sample and no structures or features of 
partially dissolved protein particles are observed. 
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Figure 4-1. SEM micrographs of albumin nanoparticles harvested on medical grade 
adhesive. 
 
 
Figure 4-2. SEM micrograph of albumin nanoparticles harvested directly using 
chloroform. 
 
 
Figure 4-3. SEM micrograph of albumin nanoparticles with siRNA harvested on 
adhesive. 
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Figure 4-4. SEM micrographs of 200 nm (diameter) x 200 nm cylinders composed of 
nanomolded albumin loaded with ethylene glycol coated gadolinium oxide. 
 
 
 
 
Figure 4-5. SEM micrograph of 2 x 2 x 2 micron3 sized albumin particles harvested on 
medical grade adhesive. 
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Figure 4-6. DIC and fluorescent images of 5 x 5 x 5 micron3 particles harvested on 
Povidone and composed of albumin and rhodamineB before (A,B), during (C,D), and 
after (E,F) dissolution of particles. 
(E) (F) 
(C) (D) 
(A) (B) 
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In order to determine the effects that the PRINT process had on the proteins, 
several biophysical methods were exploited to gain a better understanding of possible 
structural affects had on the proteins during the course of the fabrication, harvesting and 
storage processes. The methods used were ATR-FTIR, differential scanning calorimetry, 
fluorescence microscopy, and circular dichroism, all of which are used to determine the 
details regarding the secondary structure of proteins. 
 
4.4.4.1.3 BCA Protein Assay. In order to determine protein concentration of free 
and harvested PRINT particles in solution, BCA protein assays were conducted. The 
protein assay combines the well-known reduction of Cu2+ to Cu1+ by protein in an 
alkaline medium with the highly sensitive and selective colorimetric detection of the 
cuprous cation (Cu1+) by bicinchoninic acid. The first step is the chelation of copper with 
protein in an alkaline environment to form a blue colored complex. In this reaction, 
known as the biuret reaction, peptides containing three or more amino acid residues form 
a colored chelate complex with cupric ions in an alkaline environment containing sodium 
potassium tartrate. This became known as the biuret reaction because a similar complex 
forms with the organic compound biuret (NH2-CO-NH-CO-NH2) and the cupric ion. 
Biuret, a product of excess urea and heat, reacts with copper to form a light blue 
tetradentate complex. 
Standard protocol was followed. Bovine serum albumin was used as standards 
and all samples were used in triplicate. Optical density was measured at 562 nm in order 
to quantify concentration of the Cu complex relative to concentration. At least five 
different concentrations of bovine albumin standards were used to create a standard 
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calibration curve. The calibration curve was used to obtain concentration values of 
unknown samples. Fresh standards were utilized for every assay. 
 
4.4.4.1.4 Fluorescence Microscopy Assay. Fluorescence intensity was measured 
for free albumin and PRINT albumin at various concentrations in PBS. The concentration 
values of a series of serial dilutions for both free and PRINT albumin were obtained from 
a BCA assay. All samples were added to wells in a 96-well black plate in triplicate. 
Fluorescence intensity was measure at excitation wavelength of 280 nm and an emission 
wavelength of 348 nm. Intensity values for both free and PRINT albumin were each 
plotted with respect to concentration (see Figure 4-7). Free and PRINT proteins at the 
same concentration showed similar fluorescence intensity suggesting the 
microenvironment of the respective tryptophan residues are not significantly different. 
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Figure 4-7. Relative fluorescence intensity of the tryptophan residue of free albumin 
compared to PRINT albumin in PBS. Fluorescence intensity of PRINT albumin is 
represented as red squares ( ) and the free insulin as blue diamonds (♦).  
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4.4.4.1.5 ATR-FTIR. The chemical composition and qualitative secondary 
structure analysis of lyophilized, free protein and the respective protein PRINT particles 
were analyzed using FTIR.  Protein PRINT particles of 5x5x5 µm square features were 
harvested directly using slight mechanical force and a glass slide and water. The 
harvested particle solution was frozen and subsequently lyophilized. Lyophilized proteins 
were analyzed by placing a small quantity of protein on a glass slide and placing the ATR 
tip into the protein. Figure 4-8 illustrates the absorbance of the amide I region of the free 
protein compared to the protein PRINT particles. (The good overlap signifies similar or 
identical secondary structure. This qualitative measure is a good indication that the 
PRINT process does not irreversibly denature the protein and that the secondary structure 
remains intact.) More of a conclusion than stating data, maybe better in discussion or in 
tying in all three methods used here. The overlapping spectra is indicative of similar or 
identical secondary structure of lyophilized free albumin and lyophilized albumin post 
PRINT process and thus the gentleness of PRINT leaving the protein unaltered and 
unaffected.  
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Figure 4-8. Absorbance of free and PRINT albumin in the amide I region using FTIR. 
Lyophilized protein samples were analyzed from 1700 to 1500 wavenumbers. Free 
albumin analysis is represented by a solid blue curve (―) and PRINT albumin analysis is 
represented by a solid red curve (―). 
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4.4.4.1.6 CD. Circular dichroism was measured in order to investigate the 
secondary structure of free albumin and PRINT albumin. Figure 4-9 clearly illustrates 
that free albumin and PRINT albumin have very similar secondary structure, as noted by 
the close overlap of the curves. As indicated in Figure 4-9 and in literature55 albumin’s 
structure consists of mostly α–helical structure. 
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Figure 4-9. CD spectra of free and PRINT albumin. Protein was prepared in water 
solutions to approximately 0.1 ug/ml (or an OD of approx 1). Measurements were taken 
over a range of wavelengths (185- 260 nm) at a frequency of every 0.5 nm. Temperature 
was maintained at 25.0 ˚C throughout the experiment. Free albumin analysis is 
represented by a solid blue curve (―) and PRINT albumin analysis is represented by a 
solid red curve (―). 
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4.4.4.1.7 ELISA. In order to determine biological functionality of protein PRINT 
particles, standard sandwich ELISA analysis was conducted on free albumin and 
nanomolded albumin PRINT particles. Albumin PRINT particles used for ELISA were 
nano-molded into 200 x 200 nm cylinders cavities. Protein solutions were in the 
suggested working range (5-500 ng/mL) in sample/conjugate diluent. Negative controls 
included blank well (diluent only) and denatured free protein and denatured protein 
PRINT particles. Denatured samples for both free and PRINT albumin turned milky 
white and partially polymerized. Results, illustrated in Figure 4-10, reflect functionality 
retained for both free albumin as well as for nanomolded albumin PRINT particles. 
Results further indicate that the sequence/structure recognition of free albumin and 
albumin PRINT particles were indistinguishable.  
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Figure 4-10. ELISA analysis of biological integrity of protein following preparation of 
PRINT particles. Free and PRINT particles in PBS were diluted to various concentrations 
in the optimal detection range for human serum albumin. Proteins were heat treated to 
denature protein as a negative control. Free proteins are denoted as blue diamonds (♦), 
and denatured as yellow triangles (▲). PRINT proteins are denoted as red squares (■) 
and denatured protein as green circles (●).  
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4.4.5 Insulin, Transferrin, Hemoglobin. 
 4.4.5.1 PRINT Particle Fabrication. Transferrin and hemoglobin were 
nanomolded similar to albumin as discussed in section 4.2.3 using a 25 weight percent 
solution of protein in water. Insulin is highly crystalline as illustrated in Figure 4-11 and 
thus has poor solubility in water relative to the other proteins investigated in this Chapter. 
Less than one weight percent of insulin was soluble in water.  Various buffer systems and 
acedic acid solutions were attempted in efforts to obtain a more concentrated solution of 
insulin to nanomold. One buffer system in particular, HEPES, allowed for a ten weight 
percent solution to be obtained. Nanomolding insulin from a HEPES solution proved to 
introduce challenges caused by the buffer. Crystallization of the salt and possible 
interaction with insulin resulted in non-uniform particle fabrication as observed by SEM 
(not shown). It was established that nanomolding a simple solution containing protein 
and water only would circumvent introducing additional challenges into these systems. A 
four weight percent solution of insulin in water was made. Complete dissolution of 
insulin into water was not achieved. However with vortexing just prior to nanomolding, a 
uniformly distributed heterogeneous solution was obtained.  
 The four weight percent solution was nanomolded three times in a row using the 
same PFPE mold for complete filled. A forth pass through the roller was conducted using 
a new PET counter sheet as a polishing step. Due to insulin’s crystallinity and poor 
solubility in water at high concentrations, crystallites of insulin were visually observed to 
crash out of solution near the nip before nanomolding, leaving some insulin on top of the 
mold instead of solely residing in the mold cavities. The polishing step removed any such 
insulin from the mold surface. 
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Figure 4-11. SEM micrograph of lyophilized insulin as received. 
 
4.4.5.2 SEM, Optical Microscopy, and Confocal Microscopy. Nanomolded 
insulin, transferring and hemoglobin PRINT particles were analyzed using SEM and in 
some cases optical or confocal microscopy. Figures 4-12 and 4-13 illustrate insulin 
PRINT particles of different size and shape. Figure 4-13 especially highlights the 
versatility of the PRINT technology in fabricating precise micron sized particles of 
various shapes, potentially useful for pulmonary delivery of insulin. Optical microscopy 
was also used to analyze and monitor discrete particle fabrication by harvesting particles 
onto medical grade adhesive and subsequently dissolving the harvesting film to observe 
free flowing particles. Figure 4-14 illustrates 2x2x1 micron cubes of nanomolded insulin 
before and after dissolution of the adhesive harvest film.  
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Figure 4-12. SEM micrographs of 200 nm (diameter) x 200 nm cylinders of nanomolded 
insulin particles harvested onto medical grade adhesive. 
 
 
 
 
 
 
 
Figure 4-13. SEM micrographs of different shape and size PRINT particles composed of 
insulin; (A), (F) 2x2x4 µm Posts; (B), (C) 10 µm (length), 3 µm (width), 1 µm (height)  
boomerangs; (D), (E) 3 µm (side to side), 1 µm  (diameter hole), 1 µm  (height) hex nuts. 
(A) (B) (C)
(D) (E) (F)
 163
 
 
 
Figure 4-14. Optical microscopy images of 2 x 2 x 2 micron3 cubes of insulin particles 
before and after dissolution of harvest film. 
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A SEM micrograph illustrating 200 nm (diameter) x 200 nm cylinders of nanomolded 
hemoglobin is shown in Figure 4-15. Hemoglobin has a unique property unlike any of the 
other proteins investigated herein in its auto-fluorescence. Micron sized particles of 
hemoglobin can therefore be analyzed using fluorescent microscopy. One facile method 
to investigate denaturation of a protein is monitoring its dissolution in water. One 
characteristic of a denatured protein is that it aggregates or polymerizes, resulting in an 
insoluble fraction or entire sample. The dissolution of hemoglobin PRINT particles was 
monitored at first using fluorescence microscopy, but later found that confocal 
microscopy resulted in better quality images, illustrated in Figure 4-16. Two micron 
cubes composed of hemoglobin were harvested onto Povidone. The upper right corner of 
the image shows where the particles were dissolved and illustrated even distribution of 
fluorescence over the section of the sample. The observed cracks in the upper portion of 
the sample were obtained after drying. The lower section of the image did not come into 
contact with water and thus reflects intact particles. 
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Figure 4-15. SEM micrograph of 200 nm (diameter) x 200 nm cylinders of nanomolded 
hemoglobin. 
 
 
Figure 4-16. Confocal image of 2 x 2 x 2 µm3 cubes of hemoglobin particles harvested 
on Povidone and top portion partially dissolved. 
 166
Nanomolded transferring was also investigated using SEM. Particles of 200 nm 
cylinders harvested directly using slight mechanical force and chloroform are illustrated 
in Figure 4-17. Similar particles were also harvested onto medical grade adhesive and are 
illustrated in Figure 4-18. Figure 4-18 also contains and SEM micrograph of five micron 
cubes composed of transferring harvested on medical grade adhesive. 
 
 
 
Figure 4-17. SEM micrograph of nanomolded transferrin particles of 200 nm (diameter) 
x 200 nm cylinders harvested directly using chloroform and slight mechanical force. 
 
 
 
 
Figure 4-18. Nanomolded 5 x 5 x 5 micron3 cubes composed of transferrin harvested on 
medical grade adhesive. 
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4.4.5.3 ELISA.  Biological utility was analyzed for transferring, insulin, and 
hemoglobin using standard sandwich ELISA, similar to albumin. Free protein, protein 
PRINT, free denatured protein, and protein PRINT denatured samples were analyzed. In 
most cases denatured samples partially polymerized. Denatured insulin samples 
completely gelled and no solution sample was able to be added to wells. Results indicate 
that the sequence/structure recognition of free protein and protein PRINT particles were 
indistinguishable for insulin (Fig.4-19) and transferrin (Figure 4-21). Hemoglobin PRINT 
particles (Figure 4-20) showed less antibody binding at the same concentration compared 
to free hemoglobin, but still illustrated some binding.  
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Figure 4-19. ELISA of free and PRINT insulin to investigate biological integrity of the 
protein. Free and PRINT insulin in PBS were diluted to several concentrations for the 
optimal detection. Absorbance values were found to increase as concentration of protein 
increased. Absorbance of PRINT insulin is represented as red squares ( ) and the free 
insulin as blue diamonds (♦).  
 169
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 50 100
Concentration [ng/mL]
O
D
 @
 4
50
 n
m
free hemoglobin
free hemoglobin denatured
hemoglobin PRINT
hemoglobin PRINT
denatured
 
Figure 4-20. ELISA analysis of biological integrity of protein following preparation of 
PRINT particles. Free and PRINT particles in PBS were diluted to various concentrations 
in the optimal detection range for hemoglobin. Proteins were heat treated to denature 
protein as a negative control. Free proteins are denoted as blue diamonds (♦), and 
denatured as yellow triangles (▲). PRINT proteins are denoted as red squares (■) and 
denatured protein as green circles (●).  
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Figure 4-21. ELISA analysis of biological integrity of protein following preparation of 
PRINT particles. Free and PRINT particles in PBS were diluted to various concentrations 
in the optimal detection range for transferrin. Proteins were heat treated to denature 
protein as a negative control. Free proteins are denoted as blue diamonds (♦), and 
denatured as yellow triangles (▲). PRINT proteins are denoted as red squares (■) and 
denatured protein as green circles (●). 
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4.4.6 Interferon-beta. 
4.4.6.1 PRINT Particle Fabrication. Similar to other proteins investigated 
herein, particles of interferon-beta were fabricated as described above. Due to high cost 
of material, a ten weight percent solution in water was used instead of 25 weight percent 
as with albumin, transferring, and hemoglobin to nanomold and fabricate protein PRINT 
particles using interferon-beta. In order to ensure complete filling of the cavities in the 
PFPE mold, the ten weight percent interferon-beta solution was nanomolded three times 
using the same mold. 
The purchased interferon-beta product was received as a lyophilized powder, 
lyophilized from interferon-beta in buffer. Naturally, the lyophilized product contained 
buffer salts in the presence of interferon-beta. Since the nanomolding of interferon-beta 
was from a buffered mixture it was proven to be challenging to obtain enough PRINT 
particles for extensive physical characterization without making a vast amount of 
particles. When harvesting comparable amounts of particles that with other proteins (i.e, 
albumin) resulted in sufficient product for multiple characterizations, including ELISA 
and SEM, BCA analysis of nanomolded interferon-beta particles illustrated lower 
concentrations than the lower limit working range of five micrograms. Due to the high 
cost of the commercial product, characterizations were limited to SEM. 
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4.4.6.2 SEM. Figure 4-22 illustrates 200 nm (diameter) x 200 nm cylinders of 
nanomolded interferon-beta PRINT particles, harvested onto medical grade adhesive. A 
cell scraper was gently dragged across a section of the sample in attempts to lift particles 
from the harvest film and to illustrate discrete, monodisperse, shape- and size specific 
protein particles. 
 
 
Figure 4-22. SEM micrograph of nanomolded interferon-beta particles harvested onto 
medical grade adhesive. 
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4.4.7 Horseradish Peroxide and Trypsin. 
4.4.7.1 PRINT Particles Fabrication. Horseradish peroxidase and trypsin were 
used to fabricate nanomolded protein PRINT particles, similar to albumin. A 25 weight 
percent solution of the proteins in water was used for nanomolding as discussed 
previously. Horseradish peroxidase and trypsin are both enzymes and the utility and 
breadth of the PRINT process was challenged once again by investigating these 
biomaterials. The biophysical analysis of albumin and the functionality using ELISA for 
a number of protein PRINT samples illustrate that the PRINT process clearly does not 
significantly alter secondary structure and sequence allowing for antibody recognition 
and binding. By nanomolding two different enzymes, the activity is tested before and 
after the PRINT process. 
 
4.4.7.2 SEM. SEM was used to analyze the fabrication enzyme PRINT particles, 
similar to the other proteins investigated in this chapter. Figure 4-23 illustrates SEM 
micrographs of different size and shape horseradish peroxidase particles harvested on 
medical grade adhesive. Nanomolded trypsin particles are illustrated in Figure 2-24. 
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Figure 4-23. SEM micrographs of nanomolded 200 nm (diameter) x 200 nm cylinders 
and three micron hex nuts composed of horseradish peroxidase particles harvested onto 
medical grade adhesive. 
 
 
 
Figure 4-24. SEM micrograph of nanomolded 200 nm (diameter) 200 nm cylinders 
composed of trypsin harvested on medical grade adhesive. 
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 4.4.7.3 Enzymatic Activity Assay. To better assess true biological functionality, 
two enzymes (i.e., trypsin and HRP) were fabricated into particles and then subjected to 
standard assays to determine their activity. Enzyme solutions were prepared at various 
concentrations in order to find a working range such that that enzymatic activity could be 
followed for five minutes at an optimal OD value. In the case of trypsin, free protein 
solutions were prepared immediately before analysis. HRP and trypsin PRINT particles 
were harvested directly into PBS prior to analysis. Results indicate that free enzyme and 
enzyme PRINT particles have similar activity for HRP (Fig. 4-25) and trypsin (Figure 4-
26), respectfully.  This illustrates enzymatic activity is maintained during the PRINT 
process, supporting the ELISA results for the other proteins. 
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Figure 4-25. Enzymatic activity assay of free and PRINT horseradish peroxidase. 
Several concentrations of HRP were reacted with pyrogallol in the presence of hydrogen 
peroxide. The solution of free and PRINT HRP were prepared from lyophilized powder 
and resuspended in PBS. All reactions were measured at room temperature over the 
course of 5 min, measuring at 20 sec intervals at a wavelength of 450 nm. Concentrations 
are noted as follows: 2.5 ug/mL samples are represented with a solid line (───); 1.25 
ug/mL samples are represented with a dashed line (-- -- --); 0.63 ug/mL samples are 
represented with a dotted line (- - -); PBS is represented as a dash and dotted line in black 
(-- - --). PRINT HRP samples are illustrated in red. Free HRP are illustrated in blue. 
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Figure 4-26. Enzymatic activity assay on trypsin, free and PRINT, at different 
concentrations. Several concentrations of trypsin were reacted with N-benzoyl- L-
arginine-nitroanalide. The solution of free and PRINT trypsin were prepared from 
lyophilized powder and resuspended in PBS. All reactions were measured at room 
temperature over the course of 5 min, measuring at 20 sec intervals at a wavelength of 
380 nm. Concentrations are noted as follows: 1 mg/mL samples are represented with a 
solid line (──); 0.5 mg/mL samples are represented with a dotted line (-- -- --); 0.25 
mg/mL samples are represented with a dashed line (- - -). PRINT trypsin samples are 
illustrated in red. Free trypsin are illustrated in blue. 
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 4.4.8 Discussion. Biomaterials have proven to be effective therapeutics and are at 
the forefront of diagnostics for a variety of diseases and illnesses. Many challenges in 
developing therapeutics lie in their fabrication process. The current fabrication process of 
micro- and nanoparticle-sized biomaterial is hampered by complicated manufacturing 
steps and requires expensive high pressure equipment. Yet in the end, product yield is 
low in part due to the production of particles highly disperse in size and due to the loss of 
biofunctionality or monomer. In current literature, the shape of biological therapeutics is 
currently limited to spherical particles with little control over their precise size. 
Therefore, the development of a particle fabrication process that can indefinitely expand 
and independently control variables that influence the characteristics of the nanoparticles, 
could have a profound impact on the development of therapeutics. With such a 
fabrication process and judicious control over monodisperse size, shape, cargo 
encapsulation, composition, and surface functionalization for directed vector delivery and 
stealthing capabilities, new opportunities would launch in personalized health care. By 
fabricating protein particles without perturbing structure, conformation, and functionality, 
such a drug delivery system is realized.  
 To establish finely tuned shape and size specific protein particles of different 
compositions with the ability to independently vary individual parameters without 
altering the outcome, the PRINT process is utilized for particle fabrication using a nano-
molding technique with concentrated aqueous solutions of the respective proteins. The 
PRINT technology enables one to alter size, shape and protein formulation in an 
independent, straightforward manner without affecting the other parameters of the 
particle makeup, as described previously.56 Using this specific method, the need for 
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introducing crosslinking, co-monomers, or stabilizing agents is circumvented, thus 
avoiding potentially arising toxicity issues. 
 The versatility of the PRINT platform enables the fabrication of particles 
composed of any chemical structure or composition ranging from organic, synthetic  
polymer delivery vehicles5, 6, 57, 58 to naturally occurring biologics, such as proteins and 
hormones as previously introduced,56 but also can include enzymes and antibodies. The 
PRINT process creates a flexible framework for exploring the effects that size and shape 
of biomaterials have on delivery mechanisms and methods as well as on actual disease 
processes progression. Nanoscale particles for the intravenous delivery of anticancer 
therapeutics can be fabricated with the same ease as micron sized insulin particles for 
pulmonary delivery. Through the versatility of the PRINT technology personalized 
medicine can be realized and further customized to each patient and each therapy 
application. 
 The importance of the biomaterials and their functionality is well established and 
influences the development of novel biological and biomedical technologies. All of the 
investigated proteins herein have biological significance, thus, careful analysis and 
characterization of these sensitive molecules was warranted. Further demonstration of the 
ability to fabricate functional protein particles by the PRINT method is realized herein. 
SEM micrographs of harvested protein PRINT particles confirm the uniformity of the 
size and shape of these particles, whether individual, discrete, and loose, or in an array. 
These images verify the ability of the PRINT process to replicate nano- and micron-sized 
features of a patterned wafer with the utmost fidelity to fabricate protein particles. 
Qualitative secondary structure analysis of albumin before and after the PRINT process 
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was conducted using fluorescence microscopy and FT-IR. Significant overlap of 
absorbance in the amide I regions provides positive structure information. The 
fluorescence of the tryptophan residue of PRINT albumin is less intense at higher 
concentrations relative to free albumin, but the results do not vary significantly, 
indicating that the microenvironment around the tryptophan residue is similar. The most 
compelling data is illustrated in Figure 4-10, using CD. Tremendous overlap between free 
albumin and PRINT albumin substantiates similar secondary structure of the protein. The 
analysis confirms predominant α-helix structure for both free and PRINT albumin. As 
expected, denaturing of both free and PRINT albumin causes structure lost, as illustrated 
in Figure 4-10. 
ELISA analysis provides implications as to the biological integrity of the proteins 
as it relies upon protein-protein interactions to yield results. Complimentary to the 
biophysical analysis, this data indicates that the structure of the proteins is not greatly 
disturbed by the fabrication of particles. The ELISA investigation illustrates that antibody 
recognition and binding are minimally affected in the PRINT process, especially for 
albumin, transferrin, insulin (Figures 4-11, 4-22, and 4-20). Hemoglobin, found as a 
complex tetramer structure, shows less antibody binding after the PRINT process relative 
to its reconstituted, lyophilized free counterpart. This may largely be attributed to the 
complexity of the protein structure and the opportunity to disrupt the tertiary and 
quaternary structure of the protein.  
Moreover, the most compelling results are demonstrated by the enzymatic activity 
assays for free trypsin and HRP and their respective PRINT particles. The kinetic profiles 
clearly illustrate that the enzymatic activity of both trypsin and horseradish peroxidase is 
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retained after the PRINT process. These findings lay the foundation for fundamental 
protein research and new applications in biomedical therapeutics and delivery systems. 
In this study, the PRINT process was utilized for the facile fabrication of mono-
disperse protein particles. The PFPE molds act as nano- and micron sized lyophilization 
chambers. The biological materials analyzed retain their structure and in most cases 
complete biological functionality. These protein PRINT particles offer new opportunities 
in enhanced therapeutics and drug delivery vectors. These particles are able to be stored 
for long periods of time while in the mold and are readily harvested in a variety of ways. 
Particles can be stored in arrays on medical adhesive or excipient films over large areas. 
Though the fabrication process may need to be optimized for ultra sensitive biomolecules 
with complex secondary structures, this study clearly illustrates the amenability of the 
PRINT process to proteins. 
 
4.5 Future Work and Outlook. Complete bio-physical characterizations of the proteins 
investigated herein (aside from albumin) would be the next steps in this research effort. 
Specifically, circular dichroism and FT-IR analysis would provide (quantitative and 
qualitative) secondary structure characterization, respectfully. This data would be of 
interest for transferring, insulin, horseradish peroxidase, trypsin, but especially for 
hemoglobin with its complicated tertiary structures. To preserve structure, fabrication 
methodology might be varied for proteins like hemoglobin, which illustrated less 
effective antibody binding compared to the free protein. Furthermore, concentration 
variation may influence and reduce potential structural changes for such complex 
proteins.  
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 Long term stability studies could be employed by varying the duration of time 
that the protein PRINT particles are kept in the mold or harvested in an array from weeks 
to months prior to characterization. Additionally, the process of how filled molds are 
frozen could be monitored in order to investigate the effects of speed and temperature of 
freezing on the bio-physical properties of the protein. Modifications to the protein 
particles such as light surface stitching or crosslinking of nanomolded protein particles 
could be conducted with degradable crosslinkers through free thiol moieties of the 
protein. By these means, protein particles would stay intact in circulation for delivery 
vehicles. 
 With respect to therapeutics, nanomolded protein PRINT particles may find 
applications in a variety of areas. For example, pulmonary delivery of insulin might be 
conducted by characterizing micron sized particles of different shape composed of insulin 
using an Andersen Cascade Impactor. The effect of shape can be studied in a 
straightforward, systematic manner by fabricating micromolded insulin particle of 10 µm 
boomerangs, 3 µm hex nuts, 5 µm cubes, and 2 µm (width) x 4 µm square posts with an 
aspect ratio of 2. In a similarly facile way, ideal size from pulmonary drug delivery can 
be conducted by fabricating micron sized cubes and cylinders of varying aspect ratio with 
dimensions ranging from one to five microns. 
 In vitro and in vivo studies with therapeutic proteins for example interferon-beta, 
insulin, enzymes, and even transferrin could be conducted. In vitro studies with 
nanomolded insulin particles could include markers to investigate triggering of 
(radiolabeled) glucose uptake. Cancer cell lines exposed to nanomolded interferon-beta 
particles could be monitored for tumor killing. Delivery of metals and imaging agents 
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using transferrin could be investigated to determine if protein carrier indeed can target 
and increase uptake. Cargo encapsulation of a therapeutic could be investigated using in 
vitro and in vivo studies. In vitro and in vivo studies could investigate size and shape 
relationships of protein particles with cell internalization and overall biodistribution. A 
comparison of synthetic polymer PRINT particles to nanomolded protein particle and 
their respective biodistribution would create a thorough platform for delivery vehicle 
compositions and a variety of their applications. 
 More fundamental studies could be conducted with nanomolded protein particles 
harvested in an array and investigate reactions with the protein, studying surface 
chemistry of bulk properties. These studies lend themselves especially well for exact 
development of kinetics and thermodynamics due in part to the finite mass and volume of 
harvested particles. Systematic variation of size and shape of nanomolded proteins will 
open new opportunities for fundamental research in biochemistry. Investigating 
nanomolded proteins in the mold or harvested in an array can allow for direct observation 
of the dynamics and structural changes of these biomaterials. This unique setting can help 
researchers study the molecular basis of disease and supply information for developing 
new pharmaceuticals. 
 These proposed studies barely scratch the surface of this new field when 
microelectronics meets biotechnology. This new, ever growing area of nano- and 
biotechnology is largely still unexplored and opens up tremendous opportunities. 
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